CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | hydroxytoluene |
|
Accession: | CHEBI:24751
|
browse the term
|
Definition: | Any member of the class of toluenes carrying one or more hydroxy substituents. |
Synonyms: | related_synonym: | hydroxytoluenes |
|
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
increases activity |
ISO |
2,3-dimethylphenol results in increased activity of TRPA1 protein |
CTD |
PMID:29658714 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
increases activity |
ISO |
2,3-dimethylphenol results in increased activity of TRPV3 protein |
CTD |
PMID:29658714 |
|
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
|
|
|
G |
Car1 |
carbonic anhydrase 1 |
decreases activity |
ISO |
2,6-xylenol analog results in decreased activity of CA1 protein |
CTD |
PMID:19231207 |
|
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
|
|
G |
Car2 |
carbonic anhydrase 2 |
decreases activity |
ISO |
2,6-xylenol analog results in decreased activity of CA2 protein; 2,6-xylenol results in decreased activity of CA2 protein |
CTD |
PMID:19231207 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Gabra1 |
gamma-aminobutyric acid type A receptor subunit alpha 1 |
multiple interactions |
EXP |
2,6-xylenol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] |
CTD |
PMID:11399263 |
|
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
|
|
G |
Gabrb2 |
gamma-aminobutyric acid type A receptor subunit beta 2 |
multiple interactions |
EXP |
2,6-xylenol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] |
CTD |
PMID:11399263 |
|
NCBI chr10:26,936,592...27,156,141
Ensembl chr10:26,936,551...27,151,251
|
|
G |
Gabrg2 |
gamma-aminobutyric acid type A receptor subunit gamma 2 |
multiple interactions |
EXP |
2,6-xylenol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] |
CTD |
PMID:11399263 |
|
NCBI chr10:26,374,693...26,463,937
Ensembl chr10:26,374,694...26,464,346
|
|
G |
Scn4a |
sodium voltage-gated channel alpha subunit 4 |
multiple interactions |
ISO |
2,6-xylenol binds to and results in decreased activity of SCN4A protein |
CTD |
PMID:14662728 |
|
NCBI chr10:91,246,936...91,296,670
Ensembl chr10:91,246,936...91,296,545
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
increases activity |
ISO |
2,6-xylenol results in increased activity of TRPA1 protein |
CTD |
PMID:29658714 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
increases activity |
ISO |
2,6-xylenol results in increased activity of TRPV3 protein |
CTD |
PMID:29658714 |
|
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
|
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
affects response to substance |
ISO |
SLC7A11 gene SNP affects the susceptibility to 2-amino-4-methylphenol |
CTD |
PMID:25622337 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
|
G |
Ar |
androgen receptor |
affects binding |
EXP |
4-chloro-2-cresol binds to AR protein |
CTD |
PMID:14565775 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
affects activity |
ISO |
chlorocresol affects the activity of AHR protein |
CTD |
PMID:18294747 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ar |
androgen receptor |
affects activity multiple interactions |
ISO |
chlorocresol affects the activity of AR protein chlorocresol inhibits the reaction [Metribolone results in increased activity of AR protein] |
CTD |
PMID:18294747 PMID:18324785 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Esrrg |
estrogen-related receptor gamma |
multiple interactions affects binding |
ISO |
chlorocresol inhibits the reaction [afimoxifene binds to ESRRG protein] chlorocresol binds to ESRRG protein |
CTD |
PMID:17964775 |
|
NCBI chr13:99,167,656...99,788,016
Ensembl chr13:99,564,669...99,783,397
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
[chlorocresol results in increased activity of RYR1 protein] inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 protein]; Dantrolene inhibits the reaction [[chlorocresol results in increased activity of RYR1 protein] inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 protein]] |
CTD |
PMID:17707769 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Ryr1 |
ryanodine receptor 1 |
increases activity increases response to substance affects response to substance multiple interactions |
ISO |
chlorocresol results in increased activity of RYR1 protein RYR1 gene mutant form results in increased susceptibility to chlorocresol; RYR1 protein mutant form results in increased susceptibility to chlorocresol; RYR1 protein results in increased susceptibility to chlorocresol RYR1 protein alternative form affects the susceptibility to chlorocresol [chlorocresol results in increased activity of RYR1 protein] inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 protein]; [chlorocresol results in increased activity of RYR1 protein] which affects the localization of Calcium; [chlorocresol results in increased activity of RYR1 protein] which results in increased transport of Calcium; Dantrolene inhibits the reaction [[chlorocresol results in increased activity of RYR1 protein] inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 protein]]; Dantrolene inhibits the reaction [[chlorocresol results in increased activity of RYR1 protein] which results in increased transport of Calcium]; RYR1 protein polymorphism affects the reaction [chlorocresol results in increased secretion of Calcium] |
CTD |
PMID:12810058 PMID:15210166 PMID:16372898 PMID:17707769 PMID:18719443 PMID:19191329 PMID:19191333 PMID:21485675 More...
|
|
NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812
|
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO |
4-nitro-3-cresol results in increased expression of BAX protein Quercetin inhibits the reaction [4-nitro-3-cresol results in increased expression of BAX protein] |
CTD |
PMID:22467373 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions decreases expression |
ISO |
Quercetin inhibits the reaction [4-nitro-3-cresol results in decreased expression of BCL2L1 protein] |
CTD |
PMID:22467373 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions |
ISO |
4-nitro-3-cresol results in increased activity of CASP3 protein Quercetin inhibits the reaction [4-nitro-3-cresol results in increased activity of CASP3 protein] CASP3 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FAS mRNA]; CASP3 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FAS protein]; CASP3 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FASLG mRNA]; CASP3 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FASLG protein] |
CTD |
PMID:22467373 PMID:29307546 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity multiple interactions |
ISO |
4-nitro-3-cresol results in increased activity of CASP8 protein CASP8 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FAS mRNA]; CASP8 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FAS protein]; CASP8 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FASLG mRNA]; CASP8 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FASLG protein] |
CTD |
PMID:29307546 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Clock |
clock circadian regulator |
affects expression |
ISO |
4-nitro-3-cresol affects the expression of CLOCK mRNA |
CTD |
PMID:35654127 |
|
NCBI chr14:31,908,542...31,992,673
Ensembl chr14:31,908,566...31,990,400
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
decreases methylation affects expression |
ISO |
4-nitro-3-cresol results in decreased methylation of CRY1 promoter 4-nitro-3-cresol affects the expression of CRY1 mRNA |
CTD |
PMID:35654127 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
increases expression |
ISO |
4-nitro-3-cresol results in increased expression of CYP17A1 mRNA |
CTD |
PMID:35654127 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
decreases expression |
ISO |
4-nitro-3-cresol results in decreased expression of DNMT3B mRNA |
CTD |
PMID:35654127 |
|
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Esr2 |
estrogen receptor 2 |
increases expression |
ISO |
4-nitro-3-cresol results in increased expression of ESR2 mRNA |
CTD |
PMID:35654127 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression multiple interactions |
ISO |
4-nitro-3-cresol results in increased expression of FAS mRNA; 4-nitro-3-cresol results in increased expression of FAS protein CASP3 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FAS mRNA]; CASP3 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FAS protein]; CASP8 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FAS mRNA]; CASP8 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FAS protein] |
CTD |
PMID:29307546 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
multiple interactions increases expression |
ISO |
CASP3 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FASLG mRNA]; CASP3 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FASLG protein]; CASP8 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FASLG mRNA]; CASP8 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FASLG protein] 4-nitro-3-cresol results in increased expression of FASLG mRNA; 4-nitro-3-cresol results in increased expression of FASLG protein 4-nitro-3-cresol results in increased expression of FASL mRNA; 4-nitro-3-cresol results in increased expression of FASL protein |
CTD |
PMID:29307546 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
multiple interactions |
ISO |
[4-nitro-3-cresol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD17B4 protein |
CTD |
PMID:18336853 |
|
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
increases expression |
ISO |
4-nitro-3-cresol results in increased expression of HSD3B1 mRNA |
CTD |
PMID:35654127 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
multiple interactions |
ISO |
[4-nitro-3-cresol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of HSD3B2 protein |
CTD |
PMID:18336853 |
|
NCBI chr 2:186,095,897...186,105,354
Ensembl chr 2:186,095,897...186,101,852
|
|
G |
Il6 |
interleukin 6 |
increases expression |
ISO |
4-nitro-3-cresol results in increased expression of IL6 mRNA; 4-nitro-3-cresol results in increased expression of IL6 protein |
CTD |
PMID:36283488 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
affects expression |
ISO |
4-nitro-3-cresol affects the expression of NR1D1 mRNA |
CTD |
PMID:35654127 |
|
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
|
|
G |
Pla2g3 |
phospholipase A2, group III |
decreases expression |
EXP |
4-nitro-3-cresol results in decreased expression of PLA2G3 protein |
CTD |
PMID:29292090 |
|
NCBI chr14:78,367,625...78,373,913
Ensembl chr14:78,368,105...78,373,913
|
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions |
ISO |
croneton inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein] |
CTD |
PMID:26647222 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
|
G |
Ache |
acetylcholinesterase |
decreases activity multiple interactions |
ISO EXP |
fenamiphos results in decreased activity of ACHE protein fenamiphos binds to and results in increased phosphorylation of and results in decreased activity of ACHE protein |
CTD |
PMID:17382909 PMID:17402711 PMID:33720374 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
fenamiphos inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein] |
CTD |
PMID:33049310 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
fenamiphos binds to and results in increased activity of ESR1 protein |
CTD |
PMID:33049310 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
fenamiphos binds to and results in increased activity of ESR2 protein |
CTD |
PMID:33049310 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions affects activity |
ISO |
fenamiphos binds to and results in increased activity of NR1I2 protein fenamiphos affects the activity of NR1I2 protein |
CTD |
PMID:21115097 PMID:23611293 PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
fenamiphos binds to and results in increased activity of PPARG protein |
CTD |
PMID:33049310 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Tp53 |
tumor protein p53 |
affects activity |
ISO |
fenamiphos metabolite affects the activity of TP53 protein |
CTD |
PMID:35435491 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases response to substance |
ISO |
ABCC1 protein results in decreased susceptibility to Fenitrothion |
CTD |
PMID:12765240 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Ache |
acetylcholinesterase |
decreases activity decreases expression multiple interactions |
ISO EXP |
Fenitrothion results in decreased activity of ACHE protein Fenitrothion results in decreased expression of ACHE protein Acetylcysteine inhibits the reaction [Fenitrothion results in decreased activity of ACHE protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in decreased expression of ACHE protein]; Quercetin inhibits the reaction [Fenitrothion results in decreased activity of ACHE protein] |
CTD |
PMID:2086312 PMID:6933967 PMID:30639957 PMID:31173782 PMID:32034696 PMID:33439051 More...
|
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Ar |
androgen receptor |
multiple interactions decreases activity increases expression affects binding |
ISO |
Dihydrotestosterone inhibits the reaction [Fenitrothion results in increased activity of AR protein]; Fenitrothion analog binds to and results in decreased activity of AR protein; Fenitrothion inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Fenitrothion inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; Fenitrothion inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; Fenitrothion inhibits the reaction [Metribolone results in increased activity of AR protein] Fenitrothion inhibits the reaction [Dihydrotestosterone results in increased expression of AR protein] Fenitrothion results in decreased activity of AR protein Fenitrothion results in increased expression of AR mRNA Fenitrothion binds to AR protein |
CTD |
PMID:11222873 PMID:12676613 PMID:15064155 PMID:15253041 PMID:18324785 PMID:21251949 PMID:21310686 PMID:33049310 PMID:35951760 More...
|
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP |
Fenitrothion results in increased expression of BAX mRNA; Fenitrothion results in increased expression of BAX protein Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of BAX mRNA]; Fenitrothion promotes the reaction [Vehicle Emissions results in increased expression of BAX mRNA]; Plant Preparations inhibits the reaction [Fenitrothion promotes the reaction [Vehicle Emissions results in increased expression of BAX mRNA]]; Plant Preparations inhibits the reaction [Fenitrothion results in increased expression of BAX mRNA]; Plant Preparations inhibits the reaction [Vehicle Emissions promotes the reaction [Fenitrothion results in increased expression of BAX mRNA]]; Quercetin inhibits the reaction [Fenitrothion results in increased expression of BAX mRNA]; Quercetin inhibits the reaction [Fenitrothion results in increased expression of BAX protein]; Vehicle Emissions promotes the reaction [Fenitrothion results in increased expression of BAX mRNA] |
CTD |
PMID:31173782 PMID:32034696 PMID:32572764 PMID:33439051 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression decreases expression multiple interactions |
ISO EXP |
Fenitrothion results in increased expression of BCL2 mRNA Fenitrothion results in decreased expression of BCL2 mRNA Acetylcysteine inhibits the reaction [Fenitrothion results in decreased expression of BCL2 mRNA]; Fenitrothion promotes the reaction [Vehicle Emissions results in decreased expression of BCL2 mRNA]; Plant Preparations inhibits the reaction [Fenitrothion promotes the reaction [Vehicle Emissions results in decreased expression of BCL2 mRNA]]; Plant Preparations inhibits the reaction [Fenitrothion results in decreased expression of BCL2 mRNA]; Plant Preparations inhibits the reaction [Vehicle Emissions promotes the reaction [Fenitrothion results in decreased expression of BCL2 mRNA]]; Vehicle Emissions promotes the reaction [Fenitrothion results in decreased expression of BCL2 mRNA] |
CTD |
PMID:21298709 PMID:31173782 PMID:32572764 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
EXP |
Fenitrothion results in increased expression of CASP3 mRNA; Fenitrothion results in increased expression of CASP3 protein [Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [Fenitrothion results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of CASP3 protein]; Fenitrothion promotes the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of CASP3 mRNA]; Fenitrothion promotes the reaction [Vehicle Emissions results in increased expression of CASP3 mRNA]; Plant Preparations inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [Fenitrothion results in increased expression of CASP3 mRNA]]; Plant Preparations inhibits the reaction [Fenitrothion promotes the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of CASP3 mRNA]]; Plant Preparations inhibits the reaction [Fenitrothion promotes the reaction [Vehicle Emissions results in increased expression of CASP3 mRNA]]; Plant Preparations inhibits the reaction [Fenitrothion results in increased expression of CASP3 mRNA]; Plant Preparations inhibits the reaction [Vehicle Emissions promotes the reaction [Fenitrothion results in increased expression of CASP3 mRNA]]; Quercetin inhibits the reaction [Fenitrothion results in increased expression of CASP3 mRNA]; Quercetin inhibits the reaction [Fenitrothion results in increased expression of CASP3 protein]; Resveratrol inhibits the reaction [Fenitrothion results in increased expression of CASP3 mRNA]; Vehicle Emissions promotes the reaction [Fenitrothion results in increased expression of CASP3 mRNA] |
CTD |
PMID:31173782 PMID:32034696 PMID:32572764 PMID:33393722 PMID:33439051 PMID:34968465 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression |
EXP |
[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [Fenitrothion results in increased expression of CASP9 mRNA]; Fenitrothion promotes the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of CASP9 mRNA]; Plant Preparations inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [Fenitrothion results in increased expression of CASP9 mRNA]]; Plant Preparations inhibits the reaction [Fenitrothion promotes the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of CASP9 mRNA]]; Plant Preparations inhibits the reaction [Fenitrothion results in increased expression of CASP9 mRNA]; Quercetin inhibits the reaction [Fenitrothion results in increased expression of CASP9 mRNA]; Resveratrol inhibits the reaction [Fenitrothion results in increased expression of CASP9 mRNA] |
CTD |
PMID:33393722 PMID:33439051 PMID:34968465 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions increases activity decreases activity decreases expression |
EXP |
[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [Fenitrothion results in decreased activity of CAT protein]; Curcumin inhibits the reaction [Fenitrothion results in decreased activity of CAT protein]; Fenitrothion promotes the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased activity of CAT protein]; Fenitrothion promotes the reaction [Potassium Dichromate results in decreased expression of CAT protein]; Plant Extracts inhibits the reaction [Fenitrothion promotes the reaction [Potassium Dichromate results in decreased expression of CAT protein]]; Plant Extracts inhibits the reaction [Fenitrothion results in decreased expression of CAT protein]; Plant Extracts inhibits the reaction [Potassium Dichromate promotes the reaction [Fenitrothion results in decreased expression of CAT protein]]; Plant Preparations inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [Fenitrothion results in decreased activity of CAT protein]]; Plant Preparations inhibits the reaction [Fenitrothion promotes the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased activity of CAT protein]]; Plant Preparations inhibits the reaction [Fenitrothion results in decreased activity of CAT protein]; Plant Preparations inhibits the reaction [Vehicle Emissions promotes the reaction [Fenitrothion results in decreased activity of CAT protein]]; Potassium Dichromate promotes the reaction [Fenitrothion results in decreased expression of CAT protein]; Quercetin inhibits the reaction [Fenitrothion results in decreased activity of CAT protein]; Quercetin inhibits the reaction [Fenitrothion results in decreased expression of CAT mRNA]; Quercetin inhibits the reaction [Fenitrothion results in increased activity of CAT protein]; Resveratrol inhibits the reaction [Fenitrothion results in increased activity of CAT protein]; Vehicle Emissions promotes the reaction [Fenitrothion results in decreased activity of CAT protein] Fenitrothion results in decreased expression of CAT mRNA; Fenitrothion results in decreased expression of CAT protein |
CTD |
PMID:26264430 PMID:30578656 PMID:32034696 PMID:32572764 PMID:33393722 PMID:33439051 PMID:34802538 PMID:34968465 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cd68 |
Cd68 molecule |
increases expression multiple interactions |
EXP |
Fenitrothion results in increased expression of CD68 protein [Fenitrothion co-treated with Potassium Dichromate] results in increased expression of CD68 protein; Plant Extracts inhibits the reaction [[Fenitrothion co-treated with Potassium Dichromate] results in increased expression of CD68 protein]; Plant Extracts inhibits the reaction [Fenitrothion results in increased expression of CD68 protein] |
CTD |
PMID:30578656 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions |
EXP |
Fenitrothion results in increased expression of CDKN1A mRNA [Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [Fenitrothion results in increased expression of CDKN1A mRNA]; Fenitrothion promotes the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of CDKN1A mRNA]; Plant Preparations inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [Fenitrothion results in increased expression of CDKN1A mRNA]]; Plant Preparations inhibits the reaction [Fenitrothion promotes the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of CDKN1A mRNA]]; Plant Preparations inhibits the reaction [Fenitrothion results in increased expression of CDKN1A mRNA] |
CTD |
PMID:33393722 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity multiple interactions increases expression |
ISO EXP |
Fenitrothion results in decreased activity of CYP1A1 protein Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of CYP1A1 mRNA]; Curcumin inhibits the reaction [Fenitrothion results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:15620088 PMID:20183062 PMID:21298709 PMID:30639957 PMID:34802538 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression multiple interactions decreases activity |
ISO EXP |
Fenitrothion results in increased expression of CYP1A2 mRNA Curcumin inhibits the reaction [Fenitrothion results in increased expression of CYP1A2 mRNA] Fenitrothion results in decreased activity of CYP1A2 protein |
CTD |
PMID:20183062 PMID:22310298 PMID:22634058 PMID:34802538 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression decreases activity multiple interactions |
ISO |
Fenitrothion results in increased expression of CYP2B6 mRNA Fenitrothion results in decreased activity of CYP2B6 protein Fenitrothion inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] |
CTD |
PMID:20183062 PMID:22310298 PMID:22634058 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
decreases activity |
ISO |
Fenitrothion results in decreased activity of CYP2C8 protein |
CTD |
PMID:20183062 |
|
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions decreases activity |
ISO |
Fenitrothion inhibits the reaction [CYP2E1 protein results in increased hydroxylation of Chlorzoxazone] Fenitrothion results in decreased activity of CYP2E1 protein |
CTD |
PMID:22634058 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases activity multiple interactions increases activity increases expression |
ISO |
Fenitrothion results in decreased activity of CYP3A4 protein [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide co-treated with pyrimethanil co-treated with Fenitrothion co-treated with triadimefon co-treated with quinoxyfen co-treated with penconazole] results in increased expression of CYP3A4 mRNA Fenitrothion results in increased activity of CYP3A4 protein Fenitrothion results in increased expression of CYP3A4 mRNA |
CTD |
PMID:17293382 PMID:20183062 PMID:22310298 PMID:25028461 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
Fenitrothion binds to and results in increased activity of ESR1 protein |
CTD |
PMID:33049310 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
Fenitrothion binds to and results in increased activity of ESR2 protein |
CTD |
PMID:33049310 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Faah |
fatty acid amide hydrolase |
decreases activity |
ISO |
Fenitrothion results in decreased activity of FAAH protein |
CTD |
PMID:24361246 |
|
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions increases secretion |
EXP |
Fenitrothion promotes the reaction [Potassium Dichromate results in increased secretion of FSHB protein]; Plant Extracts inhibits the reaction [Fenitrothion promotes the reaction [Potassium Dichromate results in increased secretion of FSHB protein]]; Plant Extracts inhibits the reaction [Fenitrothion results in increased secretion of FSHB protein]; Plant Extracts inhibits the reaction [Potassium Dichromate promotes the reaction [Fenitrothion results in increased secretion of FSHB protein]]; Potassium Dichromate promotes the reaction [Fenitrothion results in increased secretion of FSHB protein] |
CTD |
PMID:30578656 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of GFAP protein] |
CTD |
PMID:31173782 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression multiple interactions |
EXP |
Fenitrothion results in increased expression of GPT protein Curcumin inhibits the reaction [Fenitrothion results in increased expression of GPT protein] |
CTD |
PMID:34802538 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions increases activity decreases activity decreases expression |
EXP |
[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [Fenitrothion results in increased activity of GSR protein]; Curcumin inhibits the reaction [Fenitrothion results in decreased activity of GSR protein]; Fenitrothion promotes the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased activity of GSR protein]; Fenitrothion promotes the reaction [Potassium Dichromate results in decreased expression of GSR protein]; Plant Extracts inhibits the reaction [Fenitrothion promotes the reaction [Potassium Dichromate results in decreased expression of GSR protein]]; Plant Extracts inhibits the reaction [Fenitrothion results in decreased expression of GSR protein]; Plant Extracts inhibits the reaction [Potassium Dichromate promotes the reaction [Fenitrothion results in decreased expression of GSR protein]]; Plant Preparations inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [Fenitrothion results in increased activity of GSR protein]]; Plant Preparations inhibits the reaction [Fenitrothion promotes the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased activity of GSR protein]]; Plant Preparations inhibits the reaction [Fenitrothion results in increased activity of GSR protein]; Potassium Dichromate promotes the reaction [Fenitrothion results in decreased expression of GSR protein]; Resveratrol inhibits the reaction [Fenitrothion results in decreased expression of GSR protein] |
CTD |
PMID:30578656 PMID:32034696 PMID:33393722 PMID:34802538 PMID:34968465 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
multiple interactions decreases expression |
EXP |
Acetylcysteine inhibits the reaction [Fenitrothion results in decreased expression of GSTA4 mRNA] |
CTD |
PMID:30639957 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
multiple interactions decreases expression |
EXP |
Quercetin inhibits the reaction [Fenitrothion results in decreased expression of HSD17B3 mRNA] |
CTD |
PMID:26264430 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
multiple interactions decreases expression |
EXP |
Quercetin inhibits the reaction [Fenitrothion results in decreased expression of HSD3B2 mRNA] |
CTD |
PMID:26264430 |
|
NCBI chr 2:186,095,897...186,105,354
Ensembl chr 2:186,095,897...186,101,852
|
|
G |
Ifng |
interferon gamma |
decreases expression |
ISO |
Fenitrothion results in decreased expression of IFNG protein |
CTD |
PMID:12108020 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Fenitrothion results in increased expression of IL1B protein] |
CTD |
PMID:30639957 PMID:34968465 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
decreases expression increases secretion multiple interactions |
ISO EXP |
Fenitrothion results in decreased expression of IL2 protein Fenitrothion results in increased secretion of IL2 protein Acetylcysteine inhibits the reaction [Fenitrothion results in increased secretion of IL2 protein] |
CTD |
PMID:12108020 PMID:31173782 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
EXP |
Fenitrothion results in increased expression of IL6 protein Resveratrol inhibits the reaction [Fenitrothion results in increased expression of IL6 protein] |
CTD |
PMID:34968465 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Jkamp |
JNK1/MAPK8-associated membrane protein |
multiple interactions increases expression |
EXP |
Resveratrol inhibits the reaction [Fenitrothion results in increased expression of JKAMP mRNA] |
CTD |
PMID:34968465 |
|
NCBI chr 6:90,648,043...90,661,985
Ensembl chr 6:90,648,160...90,662,501
|
|
G |
Lcat |
lecithin cholesterol acyltransferase |
multiple interactions decreases activity |
ISO |
Fenitrothion inhibits the reaction [[LCAT protein results in increased metabolism of Lecithins] which results in increased chemical synthesis of Cholesterol Esters] Fenitrothion results in decreased activity of LCAT protein |
CTD |
PMID:4847537 |
|
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
|
|
G |
Lhb |
luteinizing hormone subunit beta |
decreases secretion multiple interactions |
EXP |
Fenitrothion results in decreased secretion of LHB protein Quercetin inhibits the reaction [Fenitrothion results in decreased secretion of LHB protein] |
CTD |
PMID:26264430 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Mafb |
MAF bZIP transcription factor B |
multiple interactions |
ISO |
Fenitrothion inhibits the reaction [Dihydrotestosterone results in increased expression of MAFB mRNA]; Fenitrothion inhibits the reaction [Dihydrotestosterone results in increased expression of MAFB protein] |
CTD |
PMID:35951760 |
|
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
|
|
G |
Mgll |
monoglyceride lipase |
decreases activity |
ISO |
Fenitrothion analog results in decreased activity of MGLL protein |
CTD |
PMID:16449251 |
|
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
|
|
G |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
decreases activity |
ISO |
Fenitrothion analog results in decreased activity of NCEH1 protein |
CTD |
PMID:16449251 |
|
NCBI chr 2:110,074,985...110,135,592
Ensembl chr 2:110,074,957...110,135,588
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
[N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide co-treated with pyrimethanil co-treated with Fenitrothion co-treated with triadimefon co-treated with quinoxyfen co-treated with penconazole] results in increased activity of NR1I2 protein; Fenitrothion binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:25028461 PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
decreases expression multiple interactions |
EXP |
Fenitrothion results in decreased expression of NR5A1 mRNA Quercetin inhibits the reaction [Fenitrothion results in decreased expression of NR5A1 mRNA] |
CTD |
PMID:26264430 |
|
NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328
|
|
G |
Pla2g3 |
phospholipase A2, group III |
decreases expression |
EXP |
Fenitrothion results in decreased expression of PLA2G3 protein |
CTD |
PMID:29292090 |
|
NCBI chr14:78,367,625...78,373,913
Ensembl chr14:78,368,105...78,373,913
|
|
G |
Pon1 |
paraoxonase 1 |
multiple interactions decreases expression decreases activity |
EXP |
Fenitrothion promotes the reaction [Vehicle Emissions results in decreased activity of PON1 protein]; Fenitrothion promotes the reaction [Vehicle Emissions results in decreased expression of PON1 mRNA]; Plant Preparations inhibits the reaction [Fenitrothion promotes the reaction [Vehicle Emissions results in decreased activity of PON1 protein]]; Plant Preparations inhibits the reaction [Fenitrothion promotes the reaction [Vehicle Emissions results in decreased expression of PON1 mRNA]]; Plant Preparations inhibits the reaction [Fenitrothion results in decreased activity of PON1 protein]; Plant Preparations inhibits the reaction [Fenitrothion results in decreased expression of PON1 mRNA]; Plant Preparations inhibits the reaction [Vehicle Emissions promotes the reaction [Fenitrothion results in decreased activity of PON1 protein]]; Plant Preparations inhibits the reaction [Vehicle Emissions promotes the reaction [Fenitrothion results in decreased expression of PON1 mRNA]]; Quercetin inhibits the reaction [Fenitrothion results in decreased expression of PON1 mRNA]; Vehicle Emissions promotes the reaction [Fenitrothion results in decreased activity of PON1 protein]; Vehicle Emissions promotes the reaction [Fenitrothion results in decreased expression of PON1 mRNA] |
CTD |
PMID:32572764 PMID:33439051 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
Fenitrothion binds to and results in increased activity of PPARG protein |
CTD |
PMID:33049310 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Sirt1 |
sirtuin 1 |
decreases expression multiple interactions |
EXP |
Fenitrothion results in decreased expression of SIRT1 mRNA Resveratrol inhibits the reaction [Fenitrothion results in decreased expression of SIRT1 mRNA] |
CTD |
PMID:34968465 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Fenitrothion inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] |
CTD |
PMID:23770354 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
multiple interactions |
ISO |
Fenitrothion inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] |
CTD |
PMID:21561794 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases expression multiple interactions |
EXP |
Fenitrothion results in decreased expression of SOD1 mRNA Quercetin inhibits the reaction [Fenitrothion results in decreased expression of SOD1 mRNA] |
CTD |
PMID:26264430 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Thra |
thyroid hormone receptor alpha |
multiple interactions |
ISO |
Fenitrothion binds to and results in increased activity of THRA protein |
CTD |
PMID:33049310 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions |
ISO |
Fenitrothion binds to and results in increased activity of THRB protein |
CTD |
PMID:33049310 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases secretion increases expression |
EXP |
Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in increased secretion of TNF protein]; Resveratrol inhibits the reaction [Fenitrothion results in increased expression of TNF protein] |
CTD |
PMID:30639957 PMID:31173782 PMID:34968465 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions affects activity increases expression |
EXP ISO |
[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [Fenitrothion results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of TP53 mRNA]; Fenitrothion promotes the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of TP53 mRNA]; Plant Preparations inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [Fenitrothion results in increased expression of TP53 mRNA]]; Plant Preparations inhibits the reaction [Fenitrothion promotes the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of TP53 mRNA]]; Plant Preparations inhibits the reaction [Fenitrothion results in increased expression of TP53 mRNA]; Quercetin inhibits the reaction [Fenitrothion results in increased expression of TP53 mRNA]; Resveratrol inhibits the reaction [Fenitrothion results in increased expression of TP53 protein] Fenitrothion metabolite affects the activity of TP53 protein Fenitrothion results in increased expression of TP53 mRNA; Fenitrothion results in increased expression of TP53 protein |
CTD |
PMID:31173782 PMID:33393722 PMID:33439051 PMID:34968465 PMID:35435491 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Aaas |
aladin WD repeat nucleoporin |
increases expression |
ISO |
Fenthion results in increased expression of AAAS mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:133,464,315...133,483,961
Ensembl chr 7:133,464,315...133,483,961
|
|
G |
Aars1 |
alanyl-tRNA synthetase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of AARS1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147
|
|
G |
Aasdh |
aminoadipate-semialdehyde dehydrogenase |
decreases expression |
ISO |
Fenthion results in decreased expression of AASDH mRNA |
CTD |
PMID:34813904 |
|
NCBI chr14:31,255,019...31,281,802
Ensembl chr14:31,255,310...31,281,796
|
|
G |
Aatk |
apoptosis-associated tyrosine kinase |
decreases expression |
ISO |
Fenthion results in decreased expression of AATK mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:105,290,752...105,327,219
Ensembl chr10:105,291,585...105,327,112
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
decreases expression |
ISO |
Fenthion results in decreased expression of ABCB4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcd1 |
ATP binding cassette subfamily D member 1 |
increases expression |
ISO |
Fenthion results in increased expression of ABCD1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr X:151,428,334...151,450,115
Ensembl chr X:151,428,578...151,450,115
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
decreases expression |
ISO |
Fenthion results in decreased expression of ABCG8 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
|
|
G |
Abhd17a |
abhydrolase domain containing 17A, depalmitoylase |
increases expression |
ISO |
Fenthion results in increased expression of ABHD17A mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:9,124,332...9,132,762
Ensembl chr 7:9,124,332...9,130,762
|
|
G |
Abhd4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
increases expression |
ISO |
Fenthion results in increased expression of ABHD4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:27,697,384...27,716,013
Ensembl chr15:27,704,113...27,716,966
|
|
G |
Abhd8 |
abhydrolase domain containing 8 |
increases expression |
ISO |
Fenthion results in increased expression of ABHD8 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:18,144,464...18,151,201
Ensembl chr16:18,144,464...18,157,667
|
|
G |
Abtb1 |
ankyrin repeat and BTB domain containing 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of ABTB1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:121,299,302...121,305,667
Ensembl chr 4:121,299,304...121,305,620
|
|
G |
Acad8 |
acyl-CoA dehydrogenase family, member 8 |
increases expression |
ISO |
Fenthion results in increased expression of ACAD8 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:25,382,271...25,406,404
Ensembl chr 8:25,382,273...25,406,414
|
|
G |
Acbd6 |
acyl-CoA binding domain containing 6 |
decreases expression |
ISO |
Fenthion results in decreased expression of ACBD6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr13:67,726,786...67,863,392
Ensembl chr13:67,726,786...67,862,311
|
|
G |
Acd |
ACD, shelterin complex subunit and telomerase recruitment factor |
decreases expression |
ISO |
Fenthion results in decreased expression of ACD mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:33,586,739...33,589,481
Ensembl chr19:33,586,745...33,589,461
|
|
G |
Ache |
acetylcholinesterase |
decreases activity |
ISO EXP |
Fenthion results in decreased activity of ACHE protein |
CTD |
PMID:1855619 PMID:14976351 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acot13 |
acyl-CoA thioesterase 13 |
increases expression |
ISO |
Fenthion results in increased expression of ACOT13 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr17:40,240,378...40,252,851
Ensembl chr17:40,240,378...40,252,851
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
increases expression |
ISO |
Fenthion results in increased expression of ACOT4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
|
|
G |
Acot7 |
acyl-CoA thioesterase 7 |
increases expression |
ISO |
Fenthion results in increased expression of ACOT7 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:162,686,562...162,779,309
Ensembl chr 5:162,684,645...162,779,309
|
|
G |
Acp1 |
acid phosphatase 1 |
increases expression |
ISO |
Fenthion results in increased expression of ACP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:47,506,380...47,522,021
Ensembl chr 6:47,506,380...47,522,021
|
|
G |
Acsf2 |
acyl-CoA synthetase family member 2 |
increases expression |
ISO |
Fenthion results in increased expression of ACSF2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:79,504,510...79,546,714
Ensembl chr10:79,504,511...79,546,673
|
|
G |
Acsf3 |
acyl-CoA synthetase family member 3 |
increases expression |
ISO |
Fenthion results in increased expression of ACSF3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:50,835,116...50,875,557
Ensembl chr19:50,835,221...50,875,553
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
increases expression |
ISO |
Fenthion results in increased expression of ACTA1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Actb |
actin, beta |
decreases expression |
ISO |
Fenthion results in decreased expression of ACTB mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actn4 |
actinin alpha 4 |
increases expression |
ISO |
Fenthion results in increased expression of ACTN4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:84,182,783...84,251,867
Ensembl chr 1:84,182,788...84,251,847
|
|
G |
Actr1a |
actin related protein 1A |
decreases expression |
ISO |
Fenthion results in decreased expression of ACTR1A mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:245,237,821...245,256,618
Ensembl chr 1:245,237,826...245,256,495
|
|
G |
Acy3 |
aminoacylase 3 |
increases expression |
ISO |
Fenthion results in increased expression of ACY3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:201,279,751...201,285,803
Ensembl chr 1:201,279,851...201,283,175
|
|
G |
Adam9 |
ADAM metallopeptidase domain 9 |
decreases expression |
ISO |
Fenthion results in decreased expression of ADAM9 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:67,022,538...67,101,647
Ensembl chr16:67,022,655...67,100,917
|
|
G |
Adap2 |
ArfGAP with dual PH domains 2 |
increases expression |
ISO |
Fenthion results in increased expression of ADAP2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:65,138,006...65,166,147
Ensembl chr10:65,138,020...65,165,604
|
|
G |
Adcy9 |
adenylate cyclase 9 |
decreases expression |
ISO |
Fenthion results in decreased expression of ADCY9 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:11,138,966...11,262,067
Ensembl chr10:11,139,446...11,262,066
|
|
G |
Adh1c |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
increases expression |
ISO |
Fenthion results in increased expression of ADH1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
increases expression |
ISO |
Fenthion results in increased expression of ADH5 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:226,975,184...226,987,591
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adi1 |
acireductone dioxygenase 1 |
increases expression |
ISO |
Fenthion results in increased expression of ADI1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:45,306,885...45,313,847
Ensembl chr 6:45,306,841...45,313,842
|
|
G |
Adipor1 |
adiponectin receptor 1 |
increases expression |
ISO |
Fenthion results in increased expression of ADIPOR1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr13:45,859,461...45,879,248
Ensembl chr13:45,859,533...45,879,241
|
|
G |
Adrm1 |
ADRM1 26S proteasome ubiquitin receptor |
increases expression |
ISO |
Fenthion results in increased expression of ADRM1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:167,265,435...167,270,197
Ensembl chr 3:167,265,296...167,270,195
|
|
G |
Afdn |
afadin, adherens junction formation factor |
increases expression |
ISO |
Fenthion results in increased expression of AFDN mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:53,905,344...54,034,216
Ensembl chr 1:53,905,373...54,034,216
|
|
G |
Aff1 |
ALF transcription elongation factor 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of AFF1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr14:5,861,188...6,024,196
Ensembl chr14:5,863,961...6,024,729
|
|
G |
Aff4 |
ALF transcription elongation factor 4 |
decreases expression |
ISO |
Fenthion results in decreased expression of AFF4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:37,498,825...37,579,751
Ensembl chr10:37,498,825...37,579,751
|
|
G |
Afmid |
arylformamidase |
increases expression |
ISO |
Fenthion results in increased expression of AFMID mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:103,046,129...103,061,718
Ensembl chr10:103,046,180...103,061,718
|
|
G |
Aftph |
aftiphilin |
decreases expression |
ISO |
Fenthion results in decreased expression of AFTPH mRNA |
CTD |
PMID:34813904 |
|
NCBI chr14:94,871,429...94,925,625
Ensembl chr14:94,871,429...94,925,376
|
|
G |
Agap3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
increases expression |
ISO |
Fenthion results in increased expression of AGAP3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:10,674,746...10,724,848
Ensembl chr 4:10,674,064...10,725,244
|
|
G |
Agfg1 |
ArfGAP with FG repeats 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of AGFG1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:84,124,845...84,182,615
Ensembl chr 9:84,125,120...84,178,128
|
|
G |
Agfg2 |
ArfGAP with FG repeats 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of AGFG2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:19,012,228...19,048,433
Ensembl chr12:19,012,258...19,048,421
|
|
G |
Ago2 |
argonaute RISC catalytic component 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of AGO2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:105,018,202...105,105,118
Ensembl chr 7:105,029,120...105,104,974
|
|
G |
Agpat2 |
1-acylglycerol-3-phosphate O-acyltransferase 2 |
increases expression |
ISO |
Fenthion results in increased expression of AGPAT2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:9,416,837...9,428,567
Ensembl chr 3:9,416,843...9,428,371
|
|
G |
Agpat3 |
1-acylglycerol-3-phosphate O-acyltransferase 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of AGPAT3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr20:10,330,960...10,415,358
Ensembl chr20:10,384,507...10,415,358
|
|
G |
Agrn |
agrin |
decreases expression |
ISO |
Fenthion results in decreased expression of AGRN mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:166,749,306...166,782,212
Ensembl chr 5:166,749,310...166,786,003
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of AIFM1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Ak2 |
adenylate kinase 2 |
increases expression |
ISO |
Fenthion results in increased expression of AK2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:141,308,650...141,364,633
Ensembl chr 5:141,346,063...141,364,632
|
|
G |
Akap17a |
A-kinase anchoring protein 17A |
decreases expression |
ISO |
Fenthion results in decreased expression of AKAP17B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:16,310,427...16,315,166
Ensembl chr12:16,310,437...16,314,479
|
|
G |
Akap8l |
A-kinase anchoring protein 8 like |
decreases expression |
ISO |
Fenthion results in decreased expression of AKAP8L mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:11,332,671...11,362,287
Ensembl chr 7:11,332,672...11,362,275
|
|
G |
Akap9 |
A-kinase anchoring protein 9 |
decreases expression |
ISO |
Fenthion results in decreased expression of AKAP9 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
|
|
G |
Akirin1 |
akirin 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of AKIRIN1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:135,989,378...136,004,782
Ensembl chr 5:135,989,465...136,004,762
|
|
G |
Akt1s1 |
AKT1 substrate 1 |
increases expression |
ISO |
Fenthion results in increased expression of AKT1S1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:95,333,186...95,339,678
Ensembl chr 1:95,332,898...95,339,677
|
|
G |
Aktip |
AKT interacting protein |
decreases expression |
ISO |
Fenthion results in decreased expression of AKTIP mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:15,866,811...15,877,123
Ensembl chr19:15,866,928...15,886,663
|
|
G |
Alad |
aminolevulinate dehydratase |
decreases expression |
ISO |
Fenthion results in decreased expression of ALAD mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Aldob |
aldolase, fructose-bisphosphate B |
increases expression |
ISO |
Fenthion results in increased expression of ALDOB mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
increases expression |
ISO |
Fenthion results in increased expression of ALDOC mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
|
|
G |
Alg1 |
ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase |
increases expression |
ISO |
Fenthion results in increased expression of ALG1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:10,346,538...10,356,768
Ensembl chr10:10,346,536...10,356,750
|
|
G |
Alg14 |
ALG14, UDP-N-acetylglucosaminyltransferase subunit |
increases expression |
ISO |
Fenthion results in increased expression of ALG14 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:209,368,285...209,445,425
Ensembl chr 2:209,368,312...209,445,431
|
|
G |
Alg6 |
ALG6, alpha-1,3-glucosyltransferase |
increases expression |
ISO |
Fenthion results in increased expression of ALG6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:114,404,972...114,454,440
Ensembl chr 5:114,405,010...114,454,439
|
|
G |
Als2 |
alsin Rho guanine nucleotide exchange factor ALS2 |
decreases expression |
ISO |
Fenthion results in decreased expression of ALS2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:60,613,182...60,686,394
Ensembl chr 9:60,613,167...60,670,737
|
|
G |
Amdhd1 |
amidohydrolase domain containing 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of AMDHD1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:28,043,923...28,059,156
Ensembl chr 7:28,043,716...28,059,156
|
|
G |
Anapc2 |
anaphase promoting complex subunit 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of ANAPC2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:8,086,434...8,098,182
Ensembl chr 3:8,086,462...8,098,178
|
|
G |
Anapc4 |
anaphase promoting complex subunit 4 |
decreases expression |
ISO |
Fenthion results in decreased expression of ANAPC4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr14:58,125,995...58,159,253
Ensembl chr14:58,125,995...58,157,770
|
|
G |
Anapc5 |
anaphase-promoting complex subunit 5 |
decreases expression |
ISO |
Fenthion results in decreased expression of ANAPC5 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:33,748,709...33,781,709
Ensembl chr12:33,748,735...33,781,781
|
|
G |
Anapc7 |
anaphase promoting complex subunit 7 |
decreases expression |
ISO |
Fenthion results in decreased expression of ANAPC7 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:34,131,214...34,160,819
Ensembl chr12:34,133,429...34,160,005
|
|
G |
Angel2 |
angel homolog 2 |
increases expression |
ISO |
Fenthion results in increased expression of ANGEL2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr13:102,509,111...102,529,501
Ensembl chr13:102,510,589...102,529,493
|
|
G |
Ankh |
ANKH inorganic pyrophosphate transport regulator |
decreases expression |
ISO |
Fenthion results in decreased expression of ANK mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:78,153,027...78,280,181
Ensembl chr 2:78,153,026...78,280,187
|
|
G |
Ankhd1 |
ankyrin repeat and KH domain containing 1 |
increases expression |
ISO |
Fenthion results in increased expression of ANKHD1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr18:28,161,882...28,260,917
Ensembl chr18:28,162,311...28,268,024
|
|
G |
Ankrd11 |
ankyrin repeat domain containing 11 |
increases expression |
ISO |
Fenthion results in increased expression of ANKRD11 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:50,940,284...51,098,962
Ensembl chr19:50,940,299...51,098,962
|
|
G |
Ankrd16 |
ankyrin repeat domain 16 |
decreases expression |
ISO |
Fenthion results in decreased expression of ANKRD16 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr17:66,735,325...66,748,533
Ensembl chr17:66,737,261...66,748,533
|
|
G |
Ankrd28 |
ankyrin repeat domain 28 |
decreases expression |
ISO |
Fenthion results in decreased expression of ANKRD28 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:6,918,487...7,050,244
Ensembl chr16:6,914,336...7,050,249
|
|
G |
Ankrd49 |
ankyrin repeat domain 49 |
increases expression |
ISO |
Fenthion results in increased expression of ANKRD49 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:11,627,512...11,632,200
Ensembl chr 8:11,627,518...11,632,207
|
|
G |
Anpep |
alanyl aminopeptidase, membrane |
increases expression |
ISO |
Fenthion results in increased expression of ANPEP mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
|
|
G |
Anxa11 |
annexin A11 |
increases expression |
ISO |
Fenthion results in increased expression of ANXA11 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:1,412,373...1,457,814
Ensembl chr16:1,410,756...1,457,797
|
|
G |
Anxa5 |
annexin A5 |
increases expression |
ISO |
Fenthion results in increased expression of ANXA5 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
|
|
G |
Anxa6 |
annexin A6 |
increases expression |
ISO |
Fenthion results in increased expression of ANXA6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
|
|
G |
Ap1ar |
adaptor-related protein complex 1 associated regulatory protein |
decreases expression |
ISO |
Fenthion results in decreased expression of AP1AR mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:216,276,631...216,309,020
Ensembl chr 2:216,276,631...216,309,013
|
|
G |
Ap1b1 |
adaptor related protein complex 1 subunit beta 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of AP1B1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr14:79,879,482...79,930,778
Ensembl chr14:79,879,533...79,930,778
|
|
G |
Ap1g2 |
adaptor related protein complex 1 subunit gamma 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of AP1G2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:28,571,571...28,579,421
Ensembl chr15:28,571,568...28,589,004
|
|
G |
Ap1s1 |
adaptor related protein complex 1 subunit sigma 1 |
increases expression |
ISO |
Fenthion results in increased expression of AP1S1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:19,625,267...19,635,792
Ensembl chr12:19,625,332...19,756,713
|
|
G |
Ap2a1 |
adaptor related protein complex 2 subunit alpha 1 |
increases expression |
ISO |
Fenthion results in increased expression of AP2A1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:95,384,306...95,414,170
Ensembl chr 1:95,384,309...95,414,147
|
|
G |
Apeh |
acylaminoacyl-peptide hydrolase |
decreases expression |
ISO |
Fenthion results in decreased expression of APEH mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:108,773,791...108,782,903
Ensembl chr 8:108,773,794...108,782,933
|
|
G |
Aplp2 |
amyloid beta precursor like protein 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of APLP2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:29,599,230...29,662,311
Ensembl chr 8:29,599,230...29,661,855
|
|
G |
Apmap |
adipocyte plasma membrane associated protein |
decreases expression |
ISO |
Fenthion results in decreased expression of APMAP mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:139,409,021...139,437,296
Ensembl chr 3:139,409,022...139,437,341
|
|
G |
Apob |
apolipoprotein B |
decreases expression |
ISO |
Fenthion results in decreased expression of APOB mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Apoc2 |
apolipoprotein C2 |
increases expression |
ISO |
Fenthion results in increased expression of APOC2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
|
|
G |
Aqp9 |
aquaporin 9 |
decreases expression |
ISO |
Fenthion results in decreased expression of AQP9 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Dihydrotestosterone inhibits the reaction [Fenthion results in increased activity of AR protein]; Fenthion inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Fenthion inhibits the reaction [Metribolone results in increased activity of AR protein] |
CTD |
PMID:15064155 PMID:18324785 PMID:33049310 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Araf |
A-Raf proto-oncogene, serine/threonine kinase |
decreases expression |
ISO |
Fenthion results in decreased expression of ARAF mRNA |
CTD |
PMID:34813904 |
|
NCBI chr X:1,227,392...1,292,356
Ensembl chr X:1,227,392...1,239,073
|
|
G |
Arel1 |
apoptosis resistant E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of AREL1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:104,560,556...104,617,712
Ensembl chr 6:104,564,986...104,617,628
|
|
G |
Arf5 |
ARF GTPase 5 |
increases expression |
ISO |
Fenthion results in increased expression of ARF5 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:57,038,521...57,041,447
Ensembl chr 4:57,038,521...57,041,441
|
|
G |
Arfgef1 |
ARF guanine nucleotide exchange factor 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of ARFGEF1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:8,982,061...9,076,326
Ensembl chr 5:8,981,540...9,076,326
|
|
G |
Arfip1 |
ARF interacting protein 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of ARFIP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:169,843,804...169,924,136
Ensembl chr 2:169,843,801...169,923,142
|
|
G |
Arhgap17 |
Rho GTPase activating protein 17 |
decreases expression |
ISO |
Fenthion results in decreased expression of ARHGAP17 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:177,807,579...177,897,027
Ensembl chr 1:177,807,583...177,896,854
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
increases expression |
ISO |
Fenthion results in increased expression of ARHGDIB mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
|
|
G |
Arhgef11 |
Rho guanine nucleotide exchange factor 11 |
decreases expression |
ISO |
Fenthion results in decreased expression of ARHGEF11 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:173,074,383...173,195,962
Ensembl chr 2:173,074,368...173,196,010
|
|
G |
Arhgef18 |
Rho/Rac guanine nucleotide exchange factor 18 |
decreases expression |
ISO |
Fenthion results in decreased expression of ARHGEF18 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:1,395,035...1,503,082
Ensembl chr12:1,395,088...1,503,081
|
|
G |
Arhgef19 |
Rho guanine nucleotide exchange factor 19 |
decreases expression |
ISO |
Fenthion results in decreased expression of ARHGEF19 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:153,536,038...153,554,203
Ensembl chr 5:153,536,013...153,554,203
|
|
G |
Arhgef3 |
Rho guanine nucleotide exchange factor 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of ARHGEF3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:2,301,573...2,581,951
Ensembl chr16:2,300,138...2,581,945
|
|
G |
Arhgef5 |
Rho guanine nucleotide exchange factor 5 |
decreases expression |
ISO |
Fenthion results in decreased expression of ARHGEF5 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:72,087,205...72,112,316
Ensembl chr 4:72,087,247...72,111,254
|
|
G |
Arid1b |
AT-rich interaction domain 1B |
increases expression |
ISO |
Fenthion results in increased expression of ARID1B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:45,567,991...45,923,644
Ensembl chr 1:45,563,623...45,923,493
|
|
G |
Arl8b |
ARF like GTPase 8B |
decreases expression |
ISO |
Fenthion results in decreased expression of ARL8B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:141,748,634...141,792,605
Ensembl chr 4:141,748,587...141,792,596
|
|
G |
Armc6 |
armadillo repeat containing 6 |
decreases expression |
ISO |
Fenthion results in decreased expression of ARMC6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:19,191,106...19,201,528
Ensembl chr16:19,191,093...19,206,047
|
|
G |
Armh3 |
armadillo-like helical domain containing 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of ARMH3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:244,666,250...244,848,688
Ensembl chr 1:244,667,033...244,848,689
|
|
G |
Arrb2 |
arrestin, beta 2 |
increases expression |
ISO |
Fenthion results in increased expression of ARRB2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
|
|
G |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of ASB2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:122,474,754...122,511,014
Ensembl chr 6:122,474,756...122,510,854
|
|
G |
Ascc1 |
activating signal cointegrator 1 complex subunit 1 |
increases expression |
ISO |
Fenthion results in increased expression of ASCC1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr20:27,941,053...28,031,272
Ensembl chr20:27,941,283...28,031,272
|
|
G |
Asgr2 |
asialoglycoprotein receptor 2 |
increases expression |
ISO |
Fenthion results in increased expression of ASGR2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:54,821,407...54,834,624
Ensembl chr10:54,821,438...54,834,617
|
|
G |
Asl |
argininosuccinate lyase |
increases expression |
ISO |
Fenthion results in increased expression of ASL mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Aspscr1 |
ASPSCR1 tether for SLC2A4, UBX domain containing |
increases expression |
ISO |
Fenthion results in increased expression of ASPSCR1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:105,952,215...105,990,059
Ensembl chr10:105,952,227...105,989,904
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
increases expression |
ISO |
Fenthion results in increased expression of ASS1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atad1 |
ATPase family, AAA domain containing 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of ATAD1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:230,544,227...230,610,524
Ensembl chr 1:230,544,047...230,596,548
|
|
G |
Atf6b |
activating transcription factor 6 beta |
decreases expression |
ISO |
Fenthion results in decreased expression of ATF6B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr20:4,090,921...4,098,920
Ensembl chr20:4,090,921...4,098,894
|
|
G |
Atg101 |
autophagy related 101 |
decreases expression |
ISO |
Fenthion results in decreased expression of ATG101 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:132,398,477...132,407,643
Ensembl chr 7:132,398,483...132,407,633
|
|
G |
Atg12 |
autophagy related 12 |
decreases expression |
ISO |
Fenthion results in decreased expression of ATG12 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atg16l1 |
autophagy related 16-like 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of ATG16L1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:88,420,737...88,457,530
Ensembl chr 9:88,422,038...88,457,529
|
|
G |
Atg2b |
autophagy related 2B |
decreases expression |
ISO |
Fenthion results in decreased expression of ATG2B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:124,522,283...124,592,412
Ensembl chr 6:124,525,523...124,592,015
|
|
G |
Atg7 |
autophagy related 7 |
increases expression |
ISO |
Fenthion results in increased expression of ATG7 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
Atm |
ATM serine/threonine kinase |
decreases expression |
ISO |
Fenthion results in decreased expression of ATM mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atosa |
atos homolog A |
decreases expression |
ISO |
Fenthion results in decreased expression of ATOSA mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:75,694,828...75,772,565
Ensembl chr 8:75,695,022...75,772,549
|
|
G |
Atp13a1 |
ATPase 13A1 |
decreases expression |
ISO |
Fenthion results in decreased expression of ATP13A1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:19,615,156...19,631,546
Ensembl chr16:19,615,160...19,631,214
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of ATP1A1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Atp23 |
ATP23 metallopeptidase and ATP synthase assembly factor homolog |
decreases expression |
ISO |
Fenthion results in decreased expression of ATP23 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:62,714,752...62,729,893
Ensembl chr 7:62,714,785...62,729,862
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
increases expression |
ISO |
Fenthion results in increased expression of ATP2A1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
increases expression |
ISO |
Fenthion results in increased expression of ATP5F1D mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929
|
|
G |
Atp5mc2 |
ATP synthase membrane subunit c locus 2 |
increases expression |
ISO |
Fenthion results in increased expression of ATP5MC2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:133,791,341...133,799,713
Ensembl chr 7:133,791,342...133,799,733
|
|
G |
Atp5mg |
ATP synthase membrane subunit G |
increases expression |
ISO |
Fenthion results in increased expression of ATP5MG mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:45,225,680...45,233,630
Ensembl chr 8:45,225,686...45,233,559
|
|
G |
Atp5mj |
ATP synthase membrane subunit j |
increases expression |
ISO |
Fenthion results in increased expression of ATP5MJ mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:131,018,737...131,024,488
Ensembl chr 1:168,472,329...168,472,610 Ensembl chr 1:168,472,329...168,472,610
|
|
G |
Atp5pb |
ATP synthase peripheral stalk-membrane subunit b |
increases expression |
ISO |
Fenthion results in increased expression of ATP5PB mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:193,424,138...193,435,418
Ensembl chr 2:193,424,047...193,435,418
|
|
G |
Atp5pf |
ATP synthase peripheral stalk subunit F6 |
increases expression |
ISO |
Fenthion results in increased expression of ATP5PF mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:23,881,594...23,889,581
Ensembl chr11:23,881,592...23,889,119
|
|
G |
Atp6ap1 |
ATPase H+ transporting accessory protein 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of ATP6AP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr X:152,079,954...152,087,034
Ensembl chr X:152,079,865...152,087,034
|
|
G |
Atp6v1g1 |
ATPase H+ transporting V1 subunit G1 |
increases expression |
ISO |
Fenthion results in increased expression of ATP6V1G1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:76,961,462...76,967,642
Ensembl chr 5:76,961,499...76,969,463
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
decreases expression |
ISO |
Fenthion results in decreased expression of ATP8B1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396
|
|
G |
Atpaf2 |
ATP synthase mitochondrial F1 complex assembly factor 2 |
increases expression |
ISO |
Fenthion results in increased expression of ATPAF2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:45,205,658...45,221,891
Ensembl chr10:45,197,441...45,221,026
|
|
G |
Atxn7l3b |
ataxin 7-like 3B |
increases expression |
ISO |
Fenthion results in increased expression of ATXN7L3B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:48,322,451...48,325,975
Ensembl chr 7:48,321,755...48,328,878
|
|
G |
Aup1 |
AUP1, lipid droplet regulating VLDL assembly factor |
increases expression |
ISO |
Fenthion results in increased expression of AUP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:115,560,274...115,563,346
Ensembl chr 4:115,560,261...115,563,346
|
|
G |
Avl9 |
AVL9 cell migration associated |
decreases expression |
ISO |
Fenthion results in decreased expression of AVL9 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:85,961,493...86,008,347
Ensembl chr 4:85,961,635...86,008,791
|
|
G |
Avpr1a |
arginine vasopressin receptor 1A |
decreases expression |
ISO |
Fenthion results in decreased expression of AVPR1A mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215
|
|
G |
Axin1 |
axin 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of AXIN1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:15,163,477...15,215,615
Ensembl chr10:15,163,684...15,215,615
|
|
G |
B3gat3 |
beta-1,3-glucuronyltransferase 3 |
increases expression |
ISO |
Fenthion results in increased expression of B3GAT3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:205,817,374...205,823,928
Ensembl chr 1:205,817,378...205,837,807
|
|
G |
B4galnt1 |
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
increases expression |
ISO |
Fenthion results in increased expression of B4GALNT1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:62,988,429...62,996,190
Ensembl chr 7:62,988,930...62,996,190
|
|
G |
B4galt1 |
beta-1,4-galactosyltransferase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of B4GALT1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
|
|
G |
B4gat1 |
beta-1,4-glucuronyltransferase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of B4GAT1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:202,343,268...202,345,490
Ensembl chr 1:202,343,240...202,346,065
|
|
G |
Bace1 |
beta-secretase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of BACE1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
|
|
G |
Bach1 |
BTB domain and CNC homolog 1 |
increases expression |
ISO |
Fenthion results in increased expression of BACH1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:26,939,429...26,974,876
Ensembl chr11:26,939,480...26,972,447
|
|
G |
Bahcc1 |
BAH domain and coiled-coil containing 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of BAHCC1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:105,526,309...105,583,320
Ensembl chr10:105,522,172...105,583,317
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Fenthion results in increased expression of BAX mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of BBC3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcas3 |
BCAS3, microtubule associated cell migration factor |
decreases expression |
ISO |
Fenthion results in decreased expression of BCAS3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:70,213,710...70,673,080
Ensembl chr10:70,214,098...70,673,080
|
|
G |
Bche |
butyrylcholinesterase |
decreases activity |
ISO |
Fenthion results in decreased activity of BCHE protein |
CTD |
PMID:24052565 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcs1l |
BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone |
decreases expression |
ISO |
Fenthion results in decreased expression of BCS1L mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:76,164,925...76,168,940
Ensembl chr 9:76,164,932...76,168,938
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of BDH1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
|
|
G |
Bet1l |
Bet1 golgi vesicular membrane trafficking protein-like |
increases expression |
ISO |
Fenthion results in increased expression of BET1L mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:195,931,407...195,935,072
Ensembl chr 1:195,931,411...195,935,040
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
increases expression |
ISO |
Fenthion results in increased expression of BHMT mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Bicral |
BICRA like chromatin remodeling complex associated protein |
decreases expression |
ISO |
Fenthion results in decreased expression of BICRAL mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:14,100,253...14,185,368
Ensembl chr 9:14,154,209...14,183,671
|
|
G |
Bloc1s1 |
biogenesis of lysosomal organelles complex-1, subunit 1 |
increases expression |
ISO |
Fenthion results in increased expression of BLOC1S1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:1,347,495...1,351,103
Ensembl chr 7:1,340,934...1,351,558
|
|
G |
Bloc1s2 |
biogenesis of lysosomal organelles complex-1, subunit 2 |
increases expression |
ISO |
Fenthion results in increased expression of BLOC1S2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:243,024,611...243,031,749
Ensembl chr 1:243,024,614...243,031,653
|
|
G |
Bltp3b |
bridge-like lipid transfer protein family member 3B |
decreases expression |
ISO |
Fenthion results in decreased expression of BLTP3B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:24,181,635...24,261,720
Ensembl chr 7:24,181,644...24,261,720
|
|
G |
Blvra |
biliverdin reductase A |
decreases expression |
ISO |
Fenthion results in decreased expression of BLVRA mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:114,340,778...114,366,048
Ensembl chr 3:114,340,838...114,366,033
|
|
G |
Bok |
BCL2 family apoptosis regulator BOK |
decreases expression |
ISO |
Fenthion results in decreased expression of BOK mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:94,223,493...94,234,476
Ensembl chr 9:94,223,389...94,234,476
|
|
G |
Bola3 |
bolA family member 3 |
increases expression |
ISO |
Fenthion results in increased expression of BOLA3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:115,853,350...115,862,797
Ensembl chr 4:115,853,350...115,862,797
|
|
G |
Bop1 |
BOP1 ribosomal biogenesis factor |
decreases expression |
ISO |
Fenthion results in decreased expression of BOP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:108,172,062...108,195,875
Ensembl chr 7:108,172,066...108,195,931
|
|
G |
Borcs6 |
BLOC-1 related complex subunit 6 |
decreases expression |
ISO |
Fenthion results in decreased expression of BORCS6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:53,760,504...53,762,358
Ensembl chr10:53,758,093...53,762,632
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression |
ISO |
Fenthion results in decreased expression of BRCA1 mRNA |
CTD |
PMID:33221015 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brd2 |
bromodomain containing 2 |
increases expression |
ISO |
Fenthion results in increased expression of BRD2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr20:4,727,078...4,735,389
Ensembl chr20:4,728,151...4,735,388
|
|
G |
Brd7 |
bromodomain containing 7 |
decreases expression |
ISO |
Fenthion results in decreased expression of BRD7 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:18,708,792...18,737,497
Ensembl chr19:18,709,022...18,737,494
|
|
G |
Brf2 |
BRF2 general transcription factor 3B subunit |
decreases expression |
ISO |
Fenthion results in decreased expression of BRF2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:64,928,334...64,933,057
Ensembl chr16:64,928,300...64,933,059
|
|
G |
Brms1 |
BRMS1, transcriptional repressor and anoikis regulator |
decreases expression |
ISO |
Fenthion results in decreased expression of BRMS1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:202,345,766...202,355,028
Ensembl chr 1:202,345,704...202,355,028
|
|
G |
Brox |
BRO1 domain and CAAX motif containing |
decreases expression |
ISO |
Fenthion results in decreased expression of BROX mRNA |
CTD |
PMID:34813904 |
|
NCBI chr13:94,920,107...94,940,189
Ensembl chr13:94,920,112...94,940,227
|
|
G |
Bscl2 |
BSCL2 lipid droplet biogenesis associated, seipin |
decreases expression |
ISO |
Fenthion results in decreased expression of BSCL2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:205,731,828...205,743,430
Ensembl chr 1:205,733,872...205,743,421
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of BST2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
|
|
G |
Btd |
biotinidase |
increases expression |
ISO |
Fenthion results in increased expression of BTD mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:6,863,068...6,894,345
Ensembl chr16:6,862,407...6,940,945
|
|
G |
Bud13 |
BUD13 homolog |
decreases expression |
ISO |
Fenthion results in decreased expression of BUD13 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:46,575,124...46,590,964
Ensembl chr 8:46,575,115...46,590,958
|
|
G |
C1qbp |
complement C1q binding protein |
increases expression |
ISO |
Fenthion results in increased expression of C1QBP mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
|
|
G |
C1rl |
complement C1r subcomponent like |
increases expression |
ISO |
Fenthion results in increased expression of C1RL mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:157,394,183...157,410,771
Ensembl chr 4:157,394,200...157,410,134
|
|
G |
C1s |
complement C1s |
increases expression |
ISO |
Fenthion results in increased expression of C1S1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
|
|
G |
C2 |
complement C2 |
decreases expression |
ISO |
Fenthion results in decreased expression of C2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
|
|
G |
C2cd2l |
C2CD2-like |
decreases expression |
ISO |
Fenthion results in decreased expression of C2CD2L mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:44,648,074...44,658,856
Ensembl chr 8:44,648,079...44,658,340
|
|
G |
C3 |
complement C3 |
decreases expression |
ISO |
Fenthion results in decreased expression of C3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C4a |
complement C4A |
decreases expression |
ISO |
Fenthion results in decreased expression of C4A mRNA |
CTD |
PMID:34813904 |
|
NCBI chr20:4,005,731...4,020,083
Ensembl chr20:4,005,731...4,020,080
|
|
G |
C4b |
complement C4B |
decreases expression |
ISO |
Fenthion results in decreased expression of C4B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
|
|
G |
C5 |
complement C5 |
decreases expression |
ISO |
Fenthion results in decreased expression of HC mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
increases expression |
ISO |
Fenthion results in increased expression of CADM1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
|
|
G |
Calm2 |
calmodulin 2 |
increases expression |
ISO |
Fenthion results in increased expression of CALM2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
|
|
G |
Calm3 |
calmodulin 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of CALM3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:77,590,668...77,597,776
Ensembl chr 1:77,589,230...77,592,207
|
|
G |
Calr |
calreticulin |
increases expression |
ISO |
Fenthion results in increased expression of CALR mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Camk1 |
calcium/calmodulin-dependent protein kinase I |
increases expression |
ISO |
Fenthion results in increased expression of CAMK1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:146,481,196...146,492,039
Ensembl chr 4:146,481,196...146,492,081
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
decreases expression |
ISO |
Fenthion results in decreased expression of CAMK2B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Camta1 |
calmodulin binding transcription activator 1 |
increases expression |
ISO |
Fenthion results in increased expression of CAMTA1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:161,510,283...162,356,902
Ensembl chr 5:161,510,283...162,356,723
|
|
G |
Camta2 |
calmodulin binding transcription activator 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of CAMTA2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:55,383,450...55,401,838
Ensembl chr10:55,383,450...55,401,558
|
|
G |
Cand1 |
cullin-associated and neddylation-dissociated 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CAND1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:54,681,114...54,719,002
Ensembl chr 7:54,680,900...54,718,993
|
|
G |
Cant1 |
calcium activated nucleotidase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CANT1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:103,637,079...103,650,240
Ensembl chr10:103,531,504...103,650,109
|
|
G |
Capn5 |
calpain 5 |
decreases expression |
ISO |
Fenthion results in decreased expression of CAPN5 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:152,416,252...152,472,923
Ensembl chr 1:152,416,252...152,472,923
|
|
G |
Capns1 |
calpain, small subunit 1 |
increases expression |
ISO |
Fenthion results in increased expression of CAPNS1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:85,444,613...85,454,861
Ensembl chr 1:85,444,608...85,454,795
|
|
G |
Capzb |
capping actin protein of muscle Z-line subunit beta |
increases expression |
ISO |
Fenthion results in increased expression of CAPZB mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:151,435,600...151,535,409
Ensembl chr 5:151,434,871...151,535,409
|
|
G |
Car14 |
carbonic anhydrase 14 |
increases expression |
ISO |
Fenthion results in increased expression of CAR14 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:183,442,263...183,449,231
Ensembl chr 2:183,441,667...183,449,693
|
|
G |
Carm1 |
coactivator-associated arginine methyltransferase 1 |
increases expression |
ISO |
Fenthion results in increased expression of CARM1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:20,097,262...20,141,950
Ensembl chr 8:20,097,254...20,147,689
|
|
G |
Cbr1 |
carbonyl reductase 1 |
increases expression |
ISO |
Fenthion results in increased expression of CBR1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Cbs |
cystathionine beta synthase |
increases expression |
ISO |
Fenthion results in increased expression of CBS mRNA |
CTD |
PMID:34813904 |
|
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
|
|
G |
Cc2d1a |
coiled-coil and C2 domain containing 1A |
decreases expression |
ISO |
Fenthion results in decreased expression of CC2D1A mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:24,011,897...24,026,937
Ensembl chr19:24,011,938...24,026,936
|
|
G |
Ccar2 |
cell cycle and apoptosis regulator 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of CCAR2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:45,212,797...45,228,001
Ensembl chr15:45,212,803...45,227,636
|
|
G |
Ccdc117 |
coiled-coil domain containing 117 |
decreases expression |
ISO |
Fenthion results in decreased expression of CCDC117 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr14:80,399,236...80,409,824
Ensembl chr14:80,400,294...80,409,659
|
|
G |
Ccdc124 |
coiled-coil domain containing 124 |
increases expression |
ISO |
Fenthion results in increased expression of CCDC124 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:18,566,745...18,572,564
Ensembl chr16:18,566,745...18,572,564
|
|
G |
Ccdc127 |
coiled-coil domain containing 127 |
decreases expression |
ISO |
Fenthion results in decreased expression of CCDC127 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:28,928,420...28,935,885
Ensembl chr 1:28,928,325...28,935,893
|
|
G |
Ccdc174 |
coiled-coil domain containing 174 |
increases expression |
ISO |
Fenthion results in increased expression of CCDC174 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:124,392,183...124,419,035
Ensembl chr 4:124,392,274...124,419,035
|
|
G |
Ccdc181 |
coiled-coil domain containing 181 |
decreases expression |
ISO |
Fenthion results in decreased expression of CCDC181 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr13:76,624,567...76,638,224
Ensembl chr13:76,624,567...76,638,224
|
|
G |
Ccdc47 |
coiled-coil domain containing 47 |
increases expression |
ISO |
Fenthion results in increased expression of CCDC47 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:91,130,303...91,148,829
Ensembl chr10:91,130,303...91,148,881
|
|
G |
Ccdc59 |
coiled-coil domain containing 59 |
increases expression |
ISO |
Fenthion results in increased expression of CCDC59 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:41,142,760...41,149,143
Ensembl chr 7:41,142,760...41,149,143
|
|
G |
Ccdc6 |
coiled-coil domain containing 6 |
decreases expression |
ISO |
Fenthion results in decreased expression of CCDC6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr20:18,432,177...18,528,186
Ensembl chr20:18,433,695...18,528,658
|
|
G |
Ccdc65 |
coiled-coil domain containing 65 |
increases expression |
ISO |
Fenthion results in increased expression of CCDC65 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:129,857,118...129,870,803
Ensembl chr 7:129,857,247...129,870,803
|
|
G |
Ccdc86 |
coiled-coil domain containing 86 |
increases expression |
ISO |
Fenthion results in increased expression of CCDC86 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:207,590,167...207,596,547
Ensembl chr 1:207,590,168...207,596,544
|
|
G |
Ccpg1 |
cell cycle progression 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CCPG1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:73,719,960...73,752,437
Ensembl chr 8:73,719,955...73,752,430
|
|
G |
Ccz1 |
CCZ1 homolog, vacuolar protein trafficking and biogenesis associated |
decreases expression |
ISO |
Fenthion results in decreased expression of CCZ1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:10,601,066...10,624,608
Ensembl chr12:10,601,056...10,624,608
|
|
G |
Cd300lg |
Cd300 molecule-like family member G |
increases expression |
ISO |
Fenthion results in increased expression of CD300LG mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:86,991,886...87,009,248
Ensembl chr10:86,991,921...87,008,733
|
|
G |
Cd47 |
Cd47 molecule |
increases expression |
ISO |
Fenthion results in increased expression of CD47 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:50,906,052...50,970,000
Ensembl chr11:50,906,177...50,969,425
|
|
G |
Cd59b |
CD59b molecule |
increases expression |
ISO |
Fenthion results in increased expression of CD59B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
|
|
G |
Cd74 |
CD74 molecule |
increases expression |
ISO |
Fenthion results in increased expression of CD74 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd81 |
Cd81 molecule |
decreases expression |
ISO |
Fenthion results in decreased expression of CD81 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
|
|
G |
Cd82 |
Cd82 molecule |
increases expression |
ISO |
Fenthion results in increased expression of CD82 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:79,387,361...79,431,847
Ensembl chr 3:79,385,887...79,431,809
|
|
G |
Cd99 |
CD99 molecule (Xg blood group) |
increases expression |
ISO |
Fenthion results in increased expression of CD99 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr20:54,418,239...54,422,882
|
|
G |
Cd99l2 |
CD99 molecule-like 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of CD99L2 mRNA |
CTD |
PMID:34813904 |
|
|
|
G |
Cdc16 |
cell division cycle 16 |
decreases expression |
ISO |
Fenthion results in decreased expression of CDC16 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:75,773,026...75,796,586
Ensembl chr16:75,773,028...75,796,550
|
|
G |
Cdc34 |
cell division cycle 34, ubiqiutin conjugating enzyme |
increases expression |
ISO |
Fenthion results in increased expression of CDC34 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:10,017,588...10,023,586
Ensembl chr 7:10,017,588...10,023,186
|
|
G |
Cdc42se1 |
CDC42 small effector 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CDC42SE1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:182,805,691...182,813,520
Ensembl chr 2:182,804,925...182,814,028
|
|
G |
Cdh1 |
cadherin 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CDH1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdipt |
CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
decreases expression |
ISO |
Fenthion results in decreased expression of CDIPT mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:181,583,098...181,587,409
Ensembl chr 1:181,583,141...181,587,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of CDK2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk5rap3 |
CDK5 regulatory subunit associated protein 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of CDK5RAP3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:81,894,393...81,903,581
Ensembl chr10:81,894,393...81,903,590
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
Fenthion results in decreased expression of CDK6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn2aipnl |
CDKN2A interacting protein N-terminal like |
decreases expression |
ISO |
Fenthion results in decreased expression of CDKN2AIPNL mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:36,231,134...36,240,569
Ensembl chr10:36,231,087...36,240,564
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
increases expression |
ISO |
Fenthion results in increased expression of CDO1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CDT1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Cdv3 |
carnitine deficiency-associated gene expressed in ventricle 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of CDV3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:103,934,006...103,947,173
Ensembl chr 8:103,933,996...103,947,192
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
increases expression |
ISO |
Fenthion results in increased expression of CEACAM1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
increases expression |
ISO |
Fenthion results in increased expression of CEBPA mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpg |
CCAAT/enhancer binding protein gamma |
increases expression |
ISO |
Fenthion results in increased expression of CEBPG mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
|
|
G |
Cenpb |
centromere protein B |
decreases expression |
ISO |
Fenthion results in decreased expression of CENPB mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:118,396,987...118,399,780
Ensembl chr 3:118,388,546...118,400,470
|
|
G |
Cenpv |
centromere protein V |
increases expression |
ISO |
Fenthion results in increased expression of CENPV mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:47,214,479...47,228,552
Ensembl chr10:47,214,490...47,228,761
|
|
G |
Cep120 |
centrosomal protein 120 |
decreases expression |
ISO |
Fenthion results in decreased expression of CEP120 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr18:47,127,979...47,189,964
Ensembl chr18:47,127,981...47,189,964
|
|
G |
Cep152 |
centrosomal protein 152 |
decreases expression |
ISO |
Fenthion results in decreased expression of CEP152 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:112,803,185...112,878,298
Ensembl chr 3:112,810,425...112,878,458 Ensembl chr 3:112,810,425...112,878,458
|
|
G |
Cep170b |
centrosomal protein 170B |
decreases expression |
ISO |
Fenthion results in decreased expression of CEP170B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:131,780,935...131,806,658
Ensembl chr 6:131,778,957...131,806,658
|
|
G |
Cep85 |
centrosomal protein 85 |
decreases expression |
ISO |
Fenthion results in decreased expression of CEP85 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:146,356,571...146,404,155
Ensembl chr 5:146,356,576...146,404,060
|
|
G |
Cfd |
complement factor D |
increases expression |
ISO |
Fenthion results in increased expression of CFD mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
|
|
G |
Cfhr1 |
complement factor H-related 1 |
increases expression |
ISO |
Fenthion results in increased expression of CFHR2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr13:51,395,583...51,410,571
Ensembl chr13:51,369,211...51,410,592
|
|
G |
Cfi |
complement factor I |
decreases expression |
ISO |
Fenthion results in decreased expression of CFI mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:218,387,990...218,430,561
|
|
G |
Cggbp1 |
CGG triplet repeat binding protein 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CGGBP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:2,565,629...2,572,869
Ensembl chr11:2,565,484...2,573,031
|
|
G |
Cgnl1 |
cingulin-like 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CGNL1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:72,273,401...72,424,842
Ensembl chr 8:72,275,645...72,422,917
|
|
G |
Chchd4 |
coiled-coil-helix-coiled-coil-helix domain containing 4 |
decreases expression |
ISO |
Fenthion results in decreased expression of CHCHD4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:123,968,264...123,977,398
Ensembl chr 4:123,968,265...123,977,414 Ensembl chr 1:123,968,265...123,977,414
|
|
G |
Chd1 |
chromodomain helicase DNA binding protein 1 |
increases expression |
ISO |
Fenthion results in increased expression of CHD1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:56,661,743...56,729,119
Ensembl chr 1:56,664,054...56,728,125
|
|
G |
Chd2 |
chromodomain helicase DNA binding protein 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of CHD2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:127,188,146...127,317,041
Ensembl chr 1:127,190,059...127,300,502
|
|
G |
Chd8 |
chromodomain helicase DNA binding protein 8 |
decreases expression |
ISO |
Fenthion results in decreased expression of CHD8 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:24,905,789...24,965,461
Ensembl chr15:24,905,789...24,951,285
|
|
G |
Chic2 |
cysteine-rich hydrophobic domain 2 |
increases expression |
ISO |
Fenthion results in increased expression of CHIC2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr14:33,157,669...33,192,015
Ensembl chr14:33,157,537...33,191,895
|
|
G |
Chka |
choline kinase alpha |
increases expression |
ISO |
Fenthion results in increased expression of CHKA mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
|
|
G |
Chmp1b |
charged multivesicular body protein 1B |
increases expression |
ISO |
Fenthion results in increased expression of CHMP1B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr18:60,740,349...60,742,879
|
|
G |
Chmp3 |
charged multivesicular body protein 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of CHMP3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:103,576,453...103,622,566
Ensembl chr 4:103,576,515...103,623,959
|
|
G |
Chpt1 |
choline phosphotransferase 1 |
increases expression |
ISO |
Fenthion results in increased expression of CHPT1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:22,866,455...22,915,111
Ensembl chr 7:22,863,027...22,915,103
|
|
G |
Chrd |
chordin |
decreases expression |
ISO |
Fenthion results in decreased expression of CHRD mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:80,171,994...80,181,166
Ensembl chr11:80,171,994...80,180,673
|
|
G |
Ciao2b |
cytosolic iron-sulfur assembly component 2B |
increases expression |
ISO |
Fenthion results in increased expression of CIAO2B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:344,194...346,068
Ensembl chr19:344,203...346,068
|
|
G |
Cib1 |
calcium and integrin binding 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CIB1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:134,178,331...134,183,895
Ensembl chr 1:134,178,331...134,213,423
|
|
G |
Cideb |
cell death-inducing DFFA-like effector b |
increases expression |
ISO |
Fenthion results in increased expression of CIDEB mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:29,252,208...29,256,482
Ensembl chr15:29,252,213...29,256,605
|
|
G |
Cilk1 |
ciliogenesis associated kinase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CILK1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:78,984,075...79,042,695
Ensembl chr 8:78,984,258...79,042,691
|
|
G |
Ckb |
creatine kinase B |
decreases expression |
ISO |
Fenthion results in decreased expression of CKB mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Cldn12 |
claudin 12 |
decreases expression |
ISO |
Fenthion results in decreased expression of CLDN12 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:28,522,659...28,533,647
Ensembl chr 4:28,522,678...28,533,801
|
|
G |
Cldn5 |
claudin 5 |
decreases expression |
ISO |
Fenthion results in decreased expression of CLDN5 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
|
|
G |
Cldn9 |
claudin 9 |
increases expression |
ISO |
Fenthion results in increased expression of CLDN9 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:12,714,137...12,715,568
|
|
G |
Cldnd1 |
claudin domain containing 1 |
increases expression |
ISO |
Fenthion results in increased expression of CLDND1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:41,883,120...41,889,471
Ensembl chr11:41,883,134...41,889,354
|
|
G |
Clec7a |
C-type lectin domain containing 7A |
increases expression |
ISO |
Fenthion results in increased expression of CLEC7A mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897
|
|
G |
Clip1 |
CAP-GLY domain containing linker protein 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CLIP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:32,910,932...33,017,891
Ensembl chr12:32,910,977...33,017,884
|
|
G |
Cln3 |
CLN3 lysosomal/endosomal transmembrane protein, battenin |
decreases expression |
ISO |
Fenthion results in decreased expression of CLN3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:181,156,071...181,169,458
Ensembl chr 1:181,156,073...181,167,434
|
|
G |
Cln5 |
CLN5, intracellular trafficking protein |
decreases expression |
ISO |
Fenthion results in decreased expression of CLN5 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:79,893,573...79,903,438
Ensembl chr15:79,893,548...79,903,438 Ensembl chr 2:79,893,548...79,903,438
|
|
G |
Clptm1 |
CLPTM1 regulator of GABA type A receptor forward trafficking |
increases expression |
ISO |
Fenthion results in increased expression of CLPTM1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:79,289,478...79,321,079
Ensembl chr 1:79,289,477...79,321,092
|
|
G |
Cmah |
cytidine monophospho-N-acetylneuraminic acid hydroxylase |
increases expression |
ISO |
Fenthion results in increased expression of CMAH mRNA |
CTD |
PMID:34813904 |
|
NCBI chr17:40,557,161...40,642,350
Ensembl chr17:40,583,667...40,642,275
|
|
G |
Cmip |
c-Maf-inducing protein |
increases expression |
ISO |
Fenthion results in increased expression of CMIP mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:45,304,597...45,510,653
Ensembl chr19:45,304,031...45,508,709
|
|
G |
Cmpk1 |
cytidine/uridine monophosphate kinase 1 |
increases expression |
ISO |
Fenthion results in increased expression of CMPK1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:128,480,301...128,507,830
Ensembl chr 5:128,480,301...128,507,830
|
|
G |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
decreases expression |
ISO |
Fenthion results in decreased expression of CMTM6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:114,422,934...114,441,034
Ensembl chr 8:114,422,921...114,441,033
|
|
G |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
increases expression |
ISO |
Fenthion results in increased expression of CMTM8 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:114,481,730...114,547,107
Ensembl chr 8:114,481,982...114,547,083
|
|
G |
Cmtr1 |
cap methyltransferase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CMTR1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr20:7,722,729...7,782,579
Ensembl chr20:7,709,713...7,766,302
|
|
G |
Cnih4 |
cornichon family member 4 |
increases expression |
ISO |
Fenthion results in increased expression of CNIH4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr13:92,910,315...92,926,428
Ensembl chr13:92,910,315...92,927,853
|
|
G |
Cnot2 |
CCR4-NOT transcription complex, subunit 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of CNOT2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:52,130,445...52,222,338
Ensembl chr 7:52,130,441...52,223,575
|
|
G |
Cnot4 |
CCR4-NOT transcription complex, subunit 4 |
increases expression |
ISO |
Fenthion results in increased expression of CNOT4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:63,712,770...63,814,355
Ensembl chr 4:63,712,770...63,814,360
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
increases expression |
ISO |
Fenthion results in increased expression of CNP mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
|
|
G |
Cnrip1 |
cannabinoid receptor interacting protein 1 |
increases expression |
ISO |
Fenthion results in increased expression of CNRIP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr14:91,462,877...91,492,739
Ensembl chr14:91,462,647...91,492,735
|
|
G |
Coa5 |
cytochrome C oxidase assembly factor 5 |
decreases expression |
ISO |
Fenthion results in decreased expression of COA5 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:39,651,459...39,664,870
|
|
G |
Cog3 |
component of oligomeric golgi complex 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of COG3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:51,020,808...51,071,288
Ensembl chr15:51,020,813...51,070,570
|
|
G |
Cog8 |
component of oligomeric golgi complex 8 |
decreases expression |
ISO |
Fenthion results in decreased expression of COG8 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:34,951,625...34,962,377
Ensembl chr19:34,951,627...34,962,397
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
increases expression |
ISO |
Fenthion results in increased expression of COL4A1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Col5a3 |
collagen type V alpha 3 chain |
increases expression |
ISO |
Fenthion results in increased expression of COL5A3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:19,304,564...19,349,809
Ensembl chr 8:19,304,571...19,349,853
|
|
G |
Comt |
catechol-O-methyltransferase |
increases expression |
ISO |
Fenthion results in increased expression of COMT mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Copa |
COPI coat complex subunit alpha |
decreases expression |
ISO |
Fenthion results in decreased expression of COPA mRNA |
CTD |
PMID:34813904 |
|
NCBI chr13:84,546,483...84,586,879
Ensembl chr13:84,545,943...84,586,874
|
|
G |
Cops3 |
COP9 signalosome subunit 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of COPS3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:44,618,115...44,652,807
Ensembl chr10:44,618,115...44,641,597
|
|
G |
Cops7a |
COP9 signalosome subunit 7A |
increases expression |
ISO |
Fenthion results in increased expression of COPS7A mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:157,766,626...157,792,632
Ensembl chr 4:157,766,588...157,773,948
|
|
G |
Cops9 |
COP9 signalosome subunit 9 |
increases expression |
ISO |
Fenthion results in increased expression of COPS9 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:93,209,843...93,214,774
Ensembl chr 9:93,209,843...93,213,317
|
|
G |
Copz1 |
COPI coat complex subunit zeta 1 |
increases expression |
ISO |
Fenthion results in increased expression of COPZ1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:134,409,523...134,435,661
Ensembl chr 7:134,409,799...134,435,662
|
|
G |
Copz2 |
COPI coat complex subunit zeta 2 |
increases expression |
ISO |
Fenthion results in increased expression of COPZ2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:81,832,441...81,845,514
Ensembl chr10:81,832,418...81,845,514
|
|
G |
Coq5 |
coenzyme Q5, methyltransferase |
increases expression |
ISO |
Fenthion results in increased expression of COQ5 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:41,316,922...41,333,855
Ensembl chr12:41,316,748...41,333,848
|
|
G |
Coq8b |
coenzyme Q8B |
increases expression |
ISO |
Fenthion results in increased expression of COQ8B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:82,525,578...82,549,182
Ensembl chr 1:82,526,568...82,549,180
|
|
G |
Coq9 |
coenzyme Q9 |
increases expression |
ISO |
Fenthion results in increased expression of COQ9 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:10,166,948...10,179,976
Ensembl chr19:10,166,951...10,179,949
|
|
G |
Coro1c |
coronin 1C |
decreases expression |
ISO |
Fenthion results in decreased expression of CORO1C mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:42,713,024...42,785,179
Ensembl chr12:42,712,991...42,785,179
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
increases expression |
ISO |
Fenthion results in increased expression of COTL1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
|
|
G |
Cox10 |
cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10 |
decreases expression |
ISO |
Fenthion results in decreased expression of COX10 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:48,630,993...48,742,805
Ensembl chr10:48,630,676...48,746,667
|
|
G |
Cox15 |
cytochrome c oxidase assembly homolog COX15 |
decreases expression |
ISO |
Fenthion results in decreased expression of COX15 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:242,605,588...242,622,279
Ensembl chr 1:242,605,588...242,622,261
|
|
G |
Cox17 |
cytochrome c oxidase copper chaperone COX17 |
increases expression |
ISO |
Fenthion results in increased expression of COX17 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:62,400,733...62,406,507
|
|
G |
Cox5b |
cytochrome c oxidase subunit 5B |
increases expression |
ISO |
Fenthion results in increased expression of COX5B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052
|
|
G |
Cox6a1 |
cytochrome c oxidase subunit 6A1 |
increases expression |
ISO |
Fenthion results in increased expression of COX6A1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:41,261,983...41,265,037
Ensembl chr12:41,261,967...41,265,041
|
|
G |
Cox6c |
cytochrome c oxidase subunit 6C |
increases expression |
ISO |
Fenthion results in increased expression of COX6C mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:67,129,265...67,142,001
Ensembl chr 7:67,111,024...67,141,963
|
|
G |
Cox7a1 |
cytochrome c oxidase subunit 7A1 |
increases expression |
ISO |
Fenthion results in increased expression of COX7A1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:85,422,162...85,447,530
Ensembl chr 1:85,441,871...85,445,151
|
|
G |
Cox7b |
cytochrome c oxidase subunit 7B |
increases expression |
ISO |
Fenthion results in increased expression of COX7B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr X:71,083,486...71,089,733
Ensembl chr X:71,083,456...71,089,732
|
|
G |
Cpn2 |
carboxypeptidase N subunit 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of CPN2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:70,486,054...70,495,937
Ensembl chr11:70,486,057...70,496,472
|
|
G |
Cpne2 |
copine 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of CPNE2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:10,434,277...10,472,146
Ensembl chr19:10,434,277...10,471,820
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of CPT2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Crcp |
CGRP receptor component |
increases expression |
ISO |
Fenthion results in increased expression of CRCP mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:26,623,968...26,659,756
Ensembl chr12:26,623,976...26,768,225
|
|
G |
Creb3 |
cAMP responsive element binding protein 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of CREB3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:57,817,865...57,823,233
Ensembl chr 5:57,817,832...57,824,390
|
|
G |
Crebbp |
CREB binding protein |
increases expression |
ISO |
Fenthion results in increased expression of CREBBP mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Crlf3 |
cytokine receptor-like factor 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of CRLF3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:65,024,228...65,060,746
Ensembl chr10:65,023,388...65,060,670
|
|
G |
Crls1 |
cardiolipin synthase 1 |
increases expression |
ISO |
Fenthion results in increased expression of CRLS1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:120,119,822...120,138,674
Ensembl chr 3:120,119,852...120,138,655
|
|
G |
Crtc3 |
CREB regulated transcription coactivator 3 |
increases expression |
ISO |
Fenthion results in increased expression of CRTC3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:134,552,830...134,655,929
Ensembl chr 1:134,554,696...134,655,500
|
|
G |
Csde1 |
cold shock domain containing E1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CSDE1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:190,546,015...190,582,787
Ensembl chr 2:190,554,980...190,582,784
|
|
G |
Csnk1g2 |
casein kinase 1, gamma 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of CSNK1G2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:9,076,739...9,095,082
Ensembl chr 7:9,076,740...9,095,052
|
|
G |
Csnk2a2 |
casein kinase 2 alpha 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of CSNK2A2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:9,556,443...9,596,080
Ensembl chr19:9,556,260...9,596,080
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CSRNP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Csrnp2 |
cysteine and serine rich nuclear protein 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of CSRNP2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:131,594,232...131,610,075
Ensembl chr 7:131,594,232...131,610,075
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
increases expression |
ISO |
Fenthion results in increased expression of CSRP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Csrp2 |
cysteine and glycine-rich protein 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of CSRP2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:46,349,109...46,367,743
Ensembl chr 7:46,348,686...46,367,745
|
|
G |
Ctc1 |
CST telomere replication complex component 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CTC1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:53,714,614...53,735,298
Ensembl chr10:53,714,644...53,735,298
|
|
G |
Ctdsp1 |
CTD small phosphatase 1 |
increases expression |
ISO |
Fenthion results in increased expression of CTDSP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:75,973,694...75,979,298
Ensembl chr 9:75,973,962...75,979,297
|
|
G |
Ctnna1 |
catenin alpha 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CTNNA1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
|
|
G |
Ctnnal1 |
catenin alpha-like 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CTNNAL1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:71,514,340...71,569,431
Ensembl chr 5:71,514,340...71,569,431
|
|
G |
Ctns |
cystinosin, lysosomal cystine transporter |
decreases expression |
ISO |
Fenthion results in decreased expression of CTNS mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:57,801,551...57,817,213
Ensembl chr10:57,801,456...57,817,120
|
|
G |
Ctsa |
cathepsin A |
increases expression |
ISO |
Fenthion results in increased expression of CTSA mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:153,569,106...153,574,983
Ensembl chr 3:153,568,381...153,576,215
|
|
G |
Cul1 |
cullin 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of CUL1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:76,551,952...76,625,830
Ensembl chr 4:76,551,983...76,627,980
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
decreases expression |
ISO |
Fenthion results in decreased expression of CXCL12 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cyb561a3 |
cytochrome b561 family, member A3 |
decreases expression |
ISO |
Fenthion results in decreased expression of CYB561A3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:207,216,185...207,237,575
Ensembl chr 1:207,226,230...207,237,571
|
|
G |
Cyb5r3 |
cytochrome b5 reductase 3 |
increases expression |
ISO |
Fenthion results in increased expression of CYB5R3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
|
|
G |
Cygb |
cytoglobin |
increases expression |
ISO |
Fenthion results in increased expression of CYGB mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
|
|
G |
Cyld |
CYLD lysine 63 deubiquitinase |
decreases expression |
ISO |
Fenthion results in decreased expression of CYLD mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:18,310,632...18,373,696
Ensembl chr19:18,314,019...18,373,658
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
affects metabolic processing |
ISO |
CYP3A4 protein affects the metabolism of Fenthion |
CTD |
PMID:17110060 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
affects metabolic processing |
ISO |
CYP3A5 protein affects the metabolism of Fenthion |
CTD |
PMID:17110060 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp46a1 |
cytochrome P450, family 46, subfamily a, polypeptide 1 |
increases expression |
ISO |
Fenthion results in increased expression of CYP46A1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:127,247,543...127,274,765
Ensembl chr 6:127,243,315...127,274,760
|
|
G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
increases expression |
ISO |
Fenthion results in increased expression of CYP4B1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
|
|
G |
Cyth4 |
cytohesin 4 |
decreases expression |
ISO |
Fenthion results in decreased expression of CYTH4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:110,152,232...110,176,726
Ensembl chr 7:110,152,272...110,176,741
|
|
G |
Dag1 |
dystroglycan 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of DAG1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:108,890,926...108,955,611
Ensembl chr 8:108,890,929...108,952,325
|
|
G |
Daglb |
diacylglycerol lipase, beta |
decreases expression |
ISO |
Fenthion results in decreased expression of DAGLB mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:11,059,732...11,102,170
Ensembl chr12:11,059,732...11,102,154
|
|
G |
Dapk3 |
death-associated protein kinase 3 |
increases expression |
ISO |
Fenthion results in increased expression of DAPK3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:8,524,182...8,532,552
Ensembl chr 7:8,524,183...8,532,558
|
|
G |
Dcaf11 |
DDB1 and CUL4 associated factor 11 |
decreases expression |
ISO |
Fenthion results in decreased expression of DCAF11 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:29,046,744...29,057,450
Ensembl chr15:29,046,826...29,057,669
|
|
G |
Dcaf15 |
DDB1 and CUL4 associated factor 15 |
decreases expression |
ISO |
Fenthion results in decreased expression of DCAF15 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:24,053,925...24,061,277
Ensembl chr19:24,053,925...24,061,277
|
|
G |
Dcaf6 |
DDB1 and CUL4 associated factor 6 |
decreases expression |
ISO |
Fenthion results in decreased expression of DCAF6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr13:77,626,257...77,727,645
Ensembl chr13:77,626,307...77,727,512
|
|
G |
Dcaf7 |
DDB1 and CUL4 associated factor 7 |
decreases expression |
ISO |
Fenthion results in decreased expression of DCAF7 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:90,974,095...90,996,275
Ensembl chr10:90,974,095...90,996,275
|
|
G |
Dcakd |
dephospho-CoA kinase domain containing |
decreases expression |
ISO |
Fenthion results in decreased expression of DCAKD mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:87,957,738...87,989,002
Ensembl chr10:87,957,740...87,980,054
|
|
G |
Dcn |
decorin |
increases expression |
ISO |
Fenthion results in increased expression of DCN mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
|
|
G |
Dcun1d4 |
defective in cullin neddylation 1 domain containing 4 |
decreases expression |
ISO |
Fenthion results in decreased expression of DCUN1D4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr14:34,652,723...34,733,122
Ensembl chr14:34,652,723...34,733,207
|
|
G |
Dda1 |
DET1 and DDB1 associated 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of DDA1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:18,156,310...18,163,938
Ensembl chr16:18,156,386...18,163,937
|
|
G |
Ddx17 |
DEAD-box helicase 17 |
decreases expression |
ISO |
Fenthion results in decreased expression of DDX17 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:111,091,127...111,109,353
Ensembl chr 7:111,089,445...111,109,193
|
|
G |
Ddx39b |
DExD-box helicase 39B |
decreases expression |
ISO |
Fenthion results in decreased expression of DDX39B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr20:3,547,702...3,585,064
Ensembl chr20:3,572,056...3,584,996
|
|
G |
Ddx54 |
DEAD-box helicase 54 |
decreases expression |
ISO |
Fenthion results in decreased expression of DDX54 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:35,934,713...35,949,956
Ensembl chr12:35,934,716...35,972,523
|
|
G |
Ddx6 |
DEAD-box helicase 6 |
increases expression |
ISO |
Fenthion results in increased expression of DDX6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405 Ensembl chr 8:44,931,974...44,964,405
|
|
G |
Decr1 |
2,4-dienoyl-CoA reductase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of DECR1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:29,411,172...29,439,054
Ensembl chr 5:29,411,172...29,439,018
|
|
G |
Dedd |
death effector domain-containing |
decreases expression |
ISO |
Fenthion results in decreased expression of DEDD mRNA |
CTD |
PMID:34813904 |
|
NCBI chr13:83,755,874...83,769,982
Ensembl chr13:83,756,108...83,769,332
|
|
G |
Dedd2 |
death effector domain containing 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of DEDD2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:80,789,084...80,807,789
Ensembl chr 1:80,792,000...80,807,714
|
|
G |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of DEGS1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr13:93,946,154...93,953,677
Ensembl chr13:93,946,157...93,953,664
|
|
G |
Dek |
DEK proto-oncogene |
increases expression |
ISO |
Fenthion results in increased expression of DEK mRNA |
CTD |
PMID:34813904 |
|
NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808
|
|
G |
Dele1 |
DAP3 binding cell death enhancer 1 |
increases expression |
ISO |
Fenthion results in increased expression of DELE1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr18:30,085,093...30,098,105
Ensembl chr18:30,085,126...30,098,756
|
|
G |
Dennd6a |
DENN domain containing 6A |
decreases expression |
ISO |
Fenthion results in decreased expression of DENND6A mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:1,837,019...1,885,420
Ensembl chr16:1,837,059...1,885,420
|
|
G |
Deptor |
DEP domain containing MTOR-interacting protein |
increases expression |
ISO |
Fenthion results in increased expression of DEPTOR mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
|
|
G |
Dera |
deoxyribose-phosphate aldolase |
decreases expression |
ISO |
Fenthion results in decreased expression of DERA mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:170,663,689...170,742,469
Ensembl chr 4:170,663,665...170,758,865
|
|
G |
Derl2 |
derlin 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of DERL2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:55,727,764...55,739,442
Ensembl chr10:55,727,643...55,739,518
|
|
G |
Desi1 |
desumoylating isopeptidase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of DESI1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:113,519,974...113,542,834
Ensembl chr 7:113,519,980...113,542,845
|
|
G |
Dexi |
Dexi homolog |
decreases expression |
ISO |
Fenthion results in decreased expression of DEXI mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:5,126,021...5,138,746
Ensembl chr10:5,137,288...5,138,738
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
increases expression |
ISO |
Fenthion results in increased expression of DGAT2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
|
|
G |
Dgcr6 |
DiGeorge syndrome critical region gene 6 |
increases expression |
ISO |
Fenthion results in increased expression of DGCR6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:82,927,725...82,932,823
Ensembl chr11:82,927,725...82,932,823
|
|
G |
Dgkd |
diacylglycerol kinase, delta |
decreases expression |
ISO |
Fenthion results in decreased expression of DGKD mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:88,516,686...88,607,349
Ensembl chr 9:88,516,715...88,607,345
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
increases expression |
ISO |
Fenthion results in increased expression of DHCR24 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
increases expression |
ISO |
Fenthion results in increased expression of DHCR7 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhrsx |
dehydrogenase/reductase X-linked |
increases expression |
ISO |
Fenthion results in increased expression of DHRSX mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:16,299,768...16,304,553
Ensembl chr12:16,299,808...16,304,552
|
|
G |
Dhx30 |
DExH-box helicase 30 |
decreases expression |
ISO |
Fenthion results in decreased expression of DHX30 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:110,064,751...110,096,954
Ensembl chr 8:110,064,752...110,097,381
|
|
G |
Dhx33 |
DEAH-box helicase 33 |
decreases expression |
ISO |
Fenthion results in decreased expression of DHX33 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:55,708,102...55,724,618
Ensembl chr10:55,705,756...55,724,567
|
|
G |
Dhx37 |
DEAH-box helicase 37 |
decreases expression |
ISO |
Fenthion results in decreased expression of DHX37 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:31,194,782...31,214,890
Ensembl chr12:31,194,859...31,216,802
|
|
G |
Dhx38 |
DEAH-box helicase 38 |
decreases expression |
ISO |
Fenthion results in decreased expression of DHX38 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:37,512,893...37,530,135
Ensembl chr19:37,512,891...37,530,140
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
decreases expression |
ISO |
Fenthion results in decreased expression of DIABLO mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
decreases activity |
ISO |
Fenthion results in decreased activity of DIO1 protein |
CTD |
PMID:29228274 |
|
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
|
|
G |
Dis3l |
DIS3-like exosome 3'-5' exoribonuclease |
decreases expression |
ISO |
Fenthion results in decreased expression of DIS3L mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:64,803,925...64,840,306
Ensembl chr 8:64,803,927...64,840,165
|
|
G |
Dlg5 |
discs large MAGUK scaffold protein 5 |
decreases expression |
ISO |
Fenthion results in decreased expression of DLG5 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:75,786...209,735
Ensembl chr15:75,786...187,837
|
|
G |
Dlst |
dihydrolipoamide S-succinyltransferase |
increases expression |
ISO |
Fenthion results in increased expression of DLST mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296
|
|
G |
Dmgdh |
dimethylglycine dehydrogenase |
decreases expression |
ISO |
Fenthion results in decreased expression of DMGDH mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:24,912,600...24,987,533
Ensembl chr 2:24,912,578...24,987,528
|
|
G |
Dnai1 |
dynein, axonemal, intermediate chain 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of DNAI1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:56,730,179...56,800,926
Ensembl chr 5:56,730,179...56,800,925
|
|
G |
Dnaja3 |
DnaJ heat shock protein family (Hsp40) member A3 |
decreases expression |
ISO |
Fenthion results in decreased expression of DNAJA3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:10,854,732...10,880,171
Ensembl chr10:10,854,732...10,880,161
|
|
G |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
decreases expression |
ISO |
Fenthion results in decreased expression of DNAJB6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659
|
|
G |
Dnajc10 |
DnaJ heat shock protein family (Hsp40) member C10 |
decreases expression |
ISO |
Fenthion results in decreased expression of DNAJC10 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:65,232,031...65,272,732
Ensembl chr 3:65,232,697...65,272,719
|
|
G |
Dnajc15 |
DnaJ heat shock protein family (Hsp40) member C15 |
increases expression |
ISO |
Fenthion results in increased expression of DNAJC15 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:53,182,060...53,249,675
Ensembl chr15:53,184,855...53,249,675
|
|
G |
Dnajc16 |
DnaJ heat shock protein family (Hsp40) member C16 |
decreases expression |
ISO |
Fenthion results in decreased expression of DNAJC16 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:154,073,372...154,106,246
Ensembl chr 5:154,075,261...154,106,136
|
|
G |
Dnajc19 |
DnaJ heat shock protein family (Hsp40) member C19 |
increases expression |
ISO |
Fenthion results in increased expression of DNAJC19 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:116,923,272...116,945,312
Ensembl chr 2:116,923,272...116,945,264
|
|
G |
Dnajc2 |
DnaJ heat shock protein family (Hsp40) member C2 |
increases expression |
ISO |
Fenthion results in increased expression of DNAJC2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:13,270,239...13,297,438
Ensembl chr 4:13,270,191...13,297,431
|
|
G |
Dnajc4 |
DnaJ heat shock protein family (Hsp40) member C4 |
decreases expression |
ISO |
Fenthion results in decreased expression of DNAJC4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:204,178,189...204,182,412
Ensembl chr 1:204,178,191...204,182,387
|
|
G |
Dnajc7 |
DnaJ heat shock protein family (Hsp40) member C7 |
decreases expression |
ISO |
Fenthion results in decreased expression of DNAJC7 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:85,518,637...85,555,079
Ensembl chr10:85,518,621...85,555,575
|
|
G |
Dnase1l3 |
deoxyribonuclease 1L3 |
increases expression |
ISO |
Fenthion results in increased expression of DNASE1L3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of DNMT1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
increases expression |
ISO |
Fenthion results in increased expression of DNPH1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
|
|
G |
Dok3 |
docking protein 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of DOK3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,109,597...9,115,188
|
|
G |
Dolpp1 |
dolichyldiphosphatase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of DOLPP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:13,666,000...13,674,312
Ensembl chr 3:13,665,823...13,674,311
|
|
G |
Dpagt1 |
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of DPAGT1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:44,664,055...44,671,102
Ensembl chr 8:44,664,071...44,671,087
|
|
G |
Dph3 |
diphthamide biosynthesis 3 |
increases expression |
ISO |
Fenthion results in increased expression of DPH3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:7,288,295...7,293,734
Ensembl chr16:7,282,705...7,291,265
|
|
G |
Dpp3 |
dipeptidylpeptidase 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of DPP3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:202,204,683...202,228,501
Ensembl chr 1:202,204,693...202,228,541
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
increases expression |
ISO |
Fenthion results in increased expression of DPP4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Dpp8 |
dipeptidylpeptidase 8 |
decreases expression |
ISO |
Fenthion results in decreased expression of DPP8 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:65,550,620...65,605,828
Ensembl chr 8:65,550,677...65,605,825
|
|
G |
Dpp9 |
dipeptidyl peptidase 9 |
increases expression |
ISO |
Fenthion results in increased expression of DPP9 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:1,011,347...1,046,337
Ensembl chr 9:1,011,351...1,046,541
|
|
G |
Dpy30 |
dpy-30 histone methyltransferase complex regulatory subunit |
increases expression |
ISO |
Fenthion results in increased expression of DPY30 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:21,120,947...21,141,720
Ensembl chr 6:21,120,947...21,141,432
|
|
G |
Dus1l |
dihydrouridine synthase 1-like |
decreases expression |
ISO |
Fenthion results in decreased expression of DUS1L mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:106,055,519...106,062,656
Ensembl chr10:106,055,519...106,062,781
|
|
G |
Dusp11 |
dual specificity phosphatase 11 |
decreases expression |
ISO |
Fenthion results in decreased expression of DUSP11 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:118,367,673...118,385,183
Ensembl chr 4:118,368,053...118,385,181
|
|
G |
Dusp23 |
dual specificity phosphatase 23 |
increases expression |
ISO |
Fenthion results in increased expression of DUSP23 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr13:85,097,899...85,100,054
Ensembl chr13:85,097,899...85,100,093
|
|
G |
Dusp3 |
dual specificity phosphatase 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of DUSP3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:86,920,014...86,933,739
Ensembl chr10:86,920,014...86,933,962
|
|
G |
Dym |
dymeclin |
decreases expression |
ISO |
Fenthion results in decreased expression of DYM mRNA |
CTD |
PMID:34813904 |
|
NCBI chr18:68,605,131...68,900,905
Ensembl chr18:68,605,185...68,900,903
|
|
G |
Dynlrb1 |
dynein light chain roadblock-type 1 |
increases expression |
ISO |
Fenthion results in increased expression of DYNLRB1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:143,742,427...143,764,227
Ensembl chr 3:143,742,586...143,764,227
|
|
G |
E2f4 |
E2F transcription factor 4 |
increases expression |
ISO |
Fenthion results in increased expression of E2F4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:33,174,396...33,181,806
Ensembl chr19:33,174,410...33,181,806
|
|
G |
Echdc2 |
enoyl CoA hydratase domain containing 2 |
increases expression |
ISO |
Fenthion results in increased expression of ECHDC2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:122,915,874...122,934,860
Ensembl chr 5:122,916,134...122,934,859
|
|
G |
Echdc3 |
enoyl CoA hydratase domain containing 3 |
increases expression |
ISO |
Fenthion results in increased expression of ECHDC3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516
|
|
G |
Ecm1 |
extracellular matrix protein 1 |
increases expression |
ISO |
Fenthion results in increased expression of ECM1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671
|
|
G |
Ecsit |
ECSIT signaling integrator |
decreases expression |
ISO |
Fenthion results in decreased expression of ECSIT mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:20,605,583...20,618,453
Ensembl chr 8:20,605,583...20,618,390
|
|
G |
Edc4 |
enhancer of mRNA decapping 4 |
decreases expression |
ISO |
Fenthion results in decreased expression of EDC4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:33,774,062...33,786,054
Ensembl chr19:33,774,055...33,787,758
|
|
G |
Edem2 |
ER degradation enhancing alpha-mannosidase like protein 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of EDEM2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:144,201,604...144,227,423
Ensembl chr 3:144,201,605...144,227,485
|
|
G |
Edf1 |
endothelial differentiation-related factor 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of EDF1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:8,377,058...8,381,363
Ensembl chr 3:8,366,613...8,381,363
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
increases expression |
ISO |
Fenthion results in increased expression of EEF2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Eeig1 |
estrogen-induced osteoclastogenesis regulator 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of EEIG1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:15,822,441...15,854,651
Ensembl chr 3:15,823,144...15,854,643
|
|
G |
Efnb1 |
ephrin B1 |
decreases expression |
ISO |
Fenthion results in decreased expression of EFNB1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr X:64,257,351...64,270,158
Ensembl chr X:64,257,351...64,270,157
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of EGLN3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
increases expression |
ISO |
Fenthion results in increased expression of EHHADH mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
|
|
G |
Eif2b3 |
eukaryotic translation initiation factor 2B subunit gamma |
decreases expression |
ISO |
Fenthion results in decreased expression of EIF2B3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:130,492,167...130,558,692
Ensembl chr 5:130,492,220...130,563,332
|
|
G |
Eif2s2 |
eukaryotic translation initiation factor 2 subunit beta |
decreases expression |
ISO |
Fenthion results in decreased expression of EIF2S2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:143,374,652...143,395,460
Ensembl chr 3:143,373,686...143,395,432
|
|
G |
Eif2s3 |
eukaryotic translation initiation factor 2 subunit gamma |
decreases expression |
ISO |
Fenthion results in decreased expression of EIF2S3X mRNA |
CTD |
PMID:34813904 |
|
NCBI chr X:58,916,513...58,939,923
Ensembl chr X:58,917,490...58,940,686
|
|
G |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
increases expression |
ISO |
Fenthion results in increased expression of EIF3B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:14,196,403...14,220,865
Ensembl chr12:14,196,403...14,220,886
|
|
G |
Eif3d |
eukaryotic translation initiation factor 3, subunit D |
decreases expression |
ISO |
Fenthion results in decreased expression of EIF3D mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:109,539,795...109,552,184
Ensembl chr 7:109,539,356...109,552,206
|
|
G |
Eif3f |
eukaryotic translation initiation factor 3, subunit F |
decreases expression |
ISO |
Fenthion results in decreased expression of EIF3F mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:162,934,220...162,943,204
Ensembl chr 1:162,934,212...162,943,204
|
|
G |
Eif3i |
eukaryotic translation initiation factor 3, subunit I |
decreases expression |
ISO |
Fenthion results in decreased expression of EIF3I mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:141,935,135...141,942,589
Ensembl chr 5:141,935,044...141,942,676
|
|
G |
Eif3l |
eukaryotic translation initiation factor 3, subunit L |
decreases expression |
ISO |
Fenthion results in decreased expression of EIF3L mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:110,652,565...110,663,614
Ensembl chr 7:110,627,107...110,663,614
|
|
G |
Eif4a1 |
eukaryotic translation initiation factor 4A1 |
decreases expression |
ISO |
Fenthion results in decreased expression of EIF4A1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:54,384,345...54,389,855
Ensembl chr10:54,384,347...54,389,858
|
|
G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
increases expression |
ISO |
Fenthion results in increased expression of EIF4A2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781
|
|
G |
Eif4e2 |
eukaryotic translation initiation factor 4E family member 2 |
increases expression |
ISO |
Fenthion results in increased expression of EIF4E2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:87,886,126...87,914,470
Ensembl chr 9:87,878,085...87,914,482
|
|
G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
increases expression |
ISO |
Fenthion results in increased expression of EIF4EBP2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr20:29,379,444...29,400,110
Ensembl chr20:29,382,668...29,399,946
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
increases expression |
ISO |
Fenthion results in increased expression of EIF5A mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
|
|
G |
Eloa |
elongin A |
decreases expression |
ISO |
Fenthion results in decreased expression of ELOA mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:148,231,600...148,246,760
Ensembl chr 5:148,231,596...148,246,765
|
|
G |
Elp2 |
elongator acetyltransferase complex subunit 2 |
increases expression |
ISO |
Fenthion results in increased expression of ELP2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr18:15,885,940...15,921,564
Ensembl chr18:15,885,934...15,921,599
|
|
G |
Elp3 |
elongator acetyltransferase complex subunit 3 |
increases expression |
ISO |
Fenthion results in increased expression of ELP3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:39,754,635...39,816,482
Ensembl chr15:39,754,632...39,816,445
|
|
G |
Emc10 |
ER membrane protein complex subunit 10 |
decreases expression |
ISO |
Fenthion results in decreased expression of EMC10 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:94,980,260...94,988,847
Ensembl chr 1:94,943,587...94,988,847
|
|
G |
Emc3 |
ER membrane protein complex subunit 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of EMC3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:146,663,065...146,678,976
Ensembl chr 4:146,663,067...146,679,029
|
|
G |
Emc6 |
ER membrane protein complex subunit 6 |
decreases expression |
ISO |
Fenthion results in decreased expression of EMC6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:57,794,072...57,795,671
Ensembl chr10:57,793,685...57,796,217
|
|
G |
Emc8 |
ER membrane protein complex subunit 8 |
increases expression |
ISO |
Fenthion results in increased expression of EMC8 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:48,708,304...48,721,626
Ensembl chr19:48,582,574...48,721,543
|
|
G |
Eng |
endoglin |
increases expression |
ISO |
Fenthion results in increased expression of ENG mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
|
|
G |
Eno1 |
enolase 1 |
increases expression |
ISO |
Fenthion results in increased expression of ENO1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
|
|
G |
Enpp4 |
ectonucleotide pyrophosphatase/phosphodiesterase 4 |
increases expression |
ISO |
Fenthion results in increased expression of ENPP4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:16,888,923...16,898,860
Ensembl chr 9:16,887,739...16,898,860
|
|
G |
Entpd4 |
ectonucleoside triphosphate diphosphohydrolase 4 |
decreases expression |
ISO |
Fenthion results in decreased expression of ENTPD4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:44,630,878...44,658,654
Ensembl chr15:44,630,873...44,658,706
|
|
G |
Ep400 |
E1A binding protein p400 |
decreases expression |
ISO |
Fenthion results in decreased expression of EP400 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:45,891,886...46,002,523
Ensembl chr12:45,891,916...45,998,861
|
|
G |
Ephb4 |
EPH receptor B4 |
decreases expression |
ISO |
Fenthion results in decreased expression of EPHB4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:19,326,411...19,351,667
Ensembl chr12:19,326,427...19,351,314
|
|
G |
Eprs1 |
glutamyl-prolyl-tRNA synthetase 1 |
increases expression |
ISO |
Fenthion results in increased expression of EPRS1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
|
|
G |
Eps15l1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of EPS15L1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:17,426,345...17,501,677
Ensembl chr16:17,426,421...17,501,677
|
|
G |
Ercc3 |
ERCC excision repair 3, TFIIH core complex helicase subunit |
decreases expression |
ISO |
Fenthion results in decreased expression of ERCC3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr18:23,883,613...23,914,326
Ensembl chr18:23,883,580...23,914,329
|
|
G |
Ercc5 |
ERCC excision repair 5, endonuclease |
decreases expression |
ISO |
Fenthion results in decreased expression of ERCC5 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472
|
|
G |
Ergic3 |
ERGIC and golgi 3 |
increases expression |
ISO |
Fenthion results in increased expression of ERGIC3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:144,525,059...144,534,813
Ensembl chr 3:144,525,092...144,534,813
|
|
G |
Eri3 |
ERI1 exoribonuclease family member 3 |
increases expression |
ISO |
Fenthion results in increased expression of ERI3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:131,016,146...131,143,347
Ensembl chr 5:131,016,126...131,143,329
|
|
G |
Erlec1 |
endoplasmic reticulum lectin 1 |
increases expression |
ISO |
Fenthion results in increased expression of ERLEC1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr14:104,655,745...104,693,508
Ensembl chr14:104,655,673...104,693,480
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
decreases expression |
ISO |
Fenthion results in decreased expression of ERP29 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
|
|
G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of ERRFI1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
Fenthion binds to and results in increased activity of ESR1 protein |
CTD |
PMID:33049310 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
Fenthion binds to and results in increased activity of ESR2 protein |
CTD |
PMID:33049310 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Esrrg |
estrogen-related receptor gamma |
increases activity |
ISO |
Fenthion results in increased activity of ESRRG protein |
CTD |
PMID:20143881 |
|
NCBI chr13:99,167,656...99,788,016
Ensembl chr13:99,564,669...99,783,397
|
|
G |
Esyt1 |
extended synaptotagmin 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of ESYT1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:928,848...946,199
Ensembl chr 7:928,848...946,199
|
|
G |
Etnppl |
ethanolamine-phosphate phospho-lyase |
increases expression |
ISO |
Fenthion results in increased expression of ETNPPL mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:219,173,048...219,194,646
Ensembl chr 2:219,172,978...219,192,212
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
decreases expression |
ISO |
Fenthion results in decreased expression of ETS2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
|
|
G |
Exoc2 |
exocyst complex component 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of EXOC2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr17:33,506,289...33,698,246
Ensembl chr17:33,506,338...33,693,289
|
|
G |
Exosc1 |
exosome component 1 |
increases expression |
ISO |
Fenthion results in increased expression of EXOSC1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:240,734,777...240,745,431
Ensembl chr 1:240,734,773...240,745,438
|
|
G |
Exosc2 |
exosome component 2 |
increases expression |
ISO |
Fenthion results in increased expression of EXOSC2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:14,962,930...14,973,645
Ensembl chr 3:14,962,917...14,973,575
|
|
G |
Exosc7 |
exosome component 7 |
decreases expression |
ISO |
Fenthion results in decreased expression of EXOSC7 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:122,773,607...122,798,943
Ensembl chr 8:122,773,591...122,799,270
|
|
G |
Ext1 |
exostosin glycosyltransferase 1 |
increases expression |
ISO |
Fenthion results in increased expression of EXT1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:84,375,769...84,654,625
Ensembl chr 7:84,375,784...84,655,357
|
|
G |
Ext2 |
exostosin glycosyltransferase 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of EXT2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:79,665,414...79,798,077
Ensembl chr 3:79,665,415...79,798,059
|
|
G |
Extl2 |
exostosin-like glycosyltransferase 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of EXTL2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:203,922,217...203,946,940
Ensembl chr 2:203,922,187...203,943,653
|
|
G |
Extl3 |
exostosin-like glycosyltransferase 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of EXTL3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:39,294,033...39,384,086
Ensembl chr15:39,293,605...39,338,898
|
|
G |
F10 |
coagulation factor X |
decreases expression |
ISO |
Fenthion results in decreased expression of F10 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
|
|
G |
F11 |
coagulation factor XI |
decreases expression |
ISO |
Fenthion results in decreased expression of F11 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:46,987,988...47,009,015
Ensembl chr16:46,986,107...47,008,437
|
|
G |
F11r |
F11 receptor |
decreases expression |
ISO |
Fenthion results in decreased expression of F11R mRNA |
CTD |
PMID:34813904 |
|
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
|
|
G |
F2 |
coagulation factor II, thrombin |
decreases expression |
ISO |
Fenthion results in decreased expression of F2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
F7 |
coagulation factor VII |
increases expression |
ISO |
Fenthion results in increased expression of F7 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
|
|
G |
Faah |
fatty acid amide hydrolase |
decreases expression |
ISO |
Fenthion results in decreased expression of FAAH mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
|
|
G |
Faap100 |
FA core complex associated protein 100 |
decreases expression |
ISO |
Fenthion results in decreased expression of FAAP100 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:105,641,677...105,653,809
Ensembl chr10:105,639,414...105,653,494
|
|
G |
Fadd |
Fas associated via death domain |
decreases expression |
ISO |
Fenthion results in decreased expression of FADD mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fads6 |
fatty acid desaturase 6 |
increases expression |
ISO |
Fenthion results in increased expression of FADS6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:100,522,981...100,538,181
Ensembl chr10:100,522,981...100,538,181
|
|
G |
Faf1 |
Fas associated factor 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of FAF1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:124,426,032...124,790,014
Ensembl chr 5:124,426,062...124,789,977
|
|
G |
Faf2 |
Fas associated factor family member 2 |
increases expression |
ISO |
Fenthion results in increased expression of FAF2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr17:9,947,211...9,989,474
Ensembl chr17:9,947,220...9,989,485
|
|
G |
Fah |
fumarylacetoacetate hydrolase |
decreases expression |
ISO |
Fenthion results in decreased expression of FAH mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
|
|
G |
Fam114a1 |
family with sequence similarity 114, member A1 |
decreases expression |
ISO |
Fenthion results in decreased expression of FAM114A1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr14:43,275,693...43,346,154
Ensembl chr14:43,275,701...43,346,174
|
|
G |
Fam13b |
family with sequence similarity 13, member B |
decreases expression |
ISO |
Fenthion results in decreased expression of FAM13B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr18:26,040,285...26,107,112
Ensembl chr18:26,040,285...26,106,587
|
|
G |
Fam167b |
family with sequence similarity 167, member B |
increases expression |
ISO |
Fenthion results in increased expression of FAM167B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:141,920,695...141,922,342
Ensembl chr 5:141,920,695...141,922,340
|
|
G |
Fam185a |
family with sequence similarity 185, member A |
decreases expression |
ISO |
Fenthion results in decreased expression of FAM185A mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:13,542,022...13,662,967
Ensembl chr 4:13,608,464...13,662,967
|
|
G |
Fam20a |
FAM20A, golgi associated secretory pathway pseudokinase |
decreases expression |
ISO |
Fenthion results in decreased expression of FAM20A mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:94,638,836...94,697,814
Ensembl chr10:94,642,850...94,697,672
|
|
G |
Fam3a |
FAM3 metabolism regulating signaling molecule A |
increases expression |
ISO |
Fenthion results in increased expression of FAM3A mRNA |
CTD |
PMID:34813904 |
|
NCBI chr X:152,166,716...152,175,327
Ensembl chr X:152,165,535...152,175,362
|
|
G |
Fam3c |
FAM3 metabolism regulating signaling molecule C |
decreases expression |
ISO |
Fenthion results in decreased expression of FAM3C mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:50,839,929...50,887,276
Ensembl chr 4:50,838,818...50,888,078
|
|
G |
Fam53a |
family with sequence similarity 53, member A |
decreases expression |
ISO |
Fenthion results in decreased expression of FAM53A mRNA |
CTD |
PMID:34813904 |
|
NCBI chr14:77,088,178...77,124,395
Ensembl chr14:77,090,723...77,124,395
|
|
G |
Fam91a1 |
family with sequence similarity 91, member A1 |
decreases expression |
ISO |
Fenthion results in decreased expression of FAM91A1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:89,969,558...90,007,546
Ensembl chr 7:89,969,605...90,007,556
|
|
G |
Fam98c |
family with sequence similarity 98, member C |
increases expression |
ISO |
Fenthion results in increased expression of FAM98C mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:84,452,806...84,456,414
Ensembl chr 1:84,452,814...84,456,385
|
|
G |
Farsb |
phenylalanyl-tRNA synthetase subunit beta |
decreases expression |
ISO |
Fenthion results in decreased expression of FARSB mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:79,887,852...79,947,082
Ensembl chr 9:79,887,842...79,947,045
|
|
G |
Fastk |
Fas-activated serine/threonine kinase |
increases expression |
ISO |
Fenthion results in increased expression of FASTK mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:10,732,273...10,736,332
Ensembl chr 4:10,732,256...10,737,430
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of FAT1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:47,177,253...47,296,261
Ensembl chr16:47,177,248...47,296,107
|
|
G |
Fbrsl1 |
fibrosin-like 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of FBRSL1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:46,231,466...46,320,607
Ensembl chr12:46,231,495...46,320,357
|
|
G |
Fbxl17 |
F-box and leucine-rich repeat protein 17 |
decreases expression |
ISO |
Fenthion results in decreased expression of FBXL17 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:102,780,573...103,206,978
Ensembl chr 9:102,782,440...103,208,950
|
|
G |
Fbxo25 |
F-box protein 25 |
decreases expression |
ISO |
Fenthion results in decreased expression of FBXO25 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:75,666,062...75,701,770
Ensembl chr16:75,667,904...75,701,696
|
|
G |
Fbxo34 |
F-box protein 34 |
increases expression |
ISO |
Fenthion results in increased expression of FBXO34 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:20,719,395...20,787,905
Ensembl chr15:20,710,629...20,787,222
|
|
G |
Fbxo38 |
F-box protein 38 |
decreases expression |
ISO |
Fenthion results in decreased expression of FBXO38 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr18:55,956,950...56,004,013
Ensembl chr18:55,956,959...56,003,961
|
|
G |
Fbxo4 |
F-box protein 4 |
decreases expression |
ISO |
Fenthion results in decreased expression of FBXO4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:53,174,798...53,187,792
Ensembl chr 2:53,174,798...53,187,792
|
|
G |
Fbxo45 |
F-box protein 45 |
decreases expression |
ISO |
Fenthion results in decreased expression of FBXO45 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:68,551,430...68,567,053
Ensembl chr11:68,551,122...68,566,800
|
|
G |
Fbxo6 |
F-box protein 6 |
decreases expression |
ISO |
Fenthion results in decreased expression of FBXO6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:158,576,729...158,582,520
Ensembl chr 5:158,576,759...158,582,525
|
|
G |
Fbxw5 |
F-box and WD repeat domain containing 5 |
decreases expression |
ISO |
Fenthion results in decreased expression of FBXW5 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:8,322,543...8,327,092
Ensembl chr 3:8,322,543...8,327,092
|
|
G |
Fermt2 |
FERM domain containing kindlin 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of FERMT2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:18,682,927...18,751,959
Ensembl chr15:18,682,927...18,751,811
|
|
G |
Fetub |
fetuin B |
increases expression |
ISO |
Fenthion results in increased expression of FETUB mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:78,082,158...78,093,022
Ensembl chr11:78,082,156...78,095,135
|
|
G |
Fezf2 |
Fez family zinc finger 2 |
increases expression |
ISO |
Fenthion results in increased expression of FEZF2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:12,768,614...12,777,554
Ensembl chr15:12,773,762...12,777,554
|
|
G |
Fgd6 |
FYVE, RhoGEF and PH domain containing 6 |
decreases expression |
ISO |
Fenthion results in decreased expression of FGD6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:28,597,609...28,712,908
Ensembl chr 7:28,597,609...28,712,456
|
|
G |
Fgg |
fibrinogen gamma chain |
decreases expression |
ISO |
Fenthion results in decreased expression of FGG mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Fgl1 |
fibrinogen-like 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of FGL1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:51,120,652...51,150,907
Ensembl chr16:51,120,694...51,151,093
|
|
G |
Fhip1b |
FHF complex subunit HOOK interacting protein 1B |
decreases expression |
ISO |
Fenthion results in decreased expression of FHIP1B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:159,718,679...159,748,449
Ensembl chr 1:159,726,004...159,748,408
|
|
G |
Fhip2b |
FHF complex subunit HOOK interacting protein 2B |
decreases expression |
ISO |
Fenthion results in decreased expression of FHIP2B mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:45,656,641...45,674,603
Ensembl chr15:45,656,647...45,674,105
|
|
G |
Fhod1 |
formin homology 2 domain containing 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of FHOD1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:33,206,492...33,225,448
Ensembl chr19:33,206,492...33,225,356
|
|
G |
Fis1 |
fission, mitochondrial 1 |
increases expression |
ISO |
Fenthion results in increased expression of FIS1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
|
|
G |
Fitm1 |
fat storage-inducing transmembrane protein 1 |
increases expression |
ISO |
Fenthion results in increased expression of FITM1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:29,064,746...29,066,015
Ensembl chr15:29,064,707...29,066,015
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
increases expression |
ISO |
Fenthion results in increased expression of FKBP1A mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
|
|
G |
Fkbp8 |
FKBP prolyl isomerase 8 |
increases expression |
ISO |
Fenthion results in increased expression of FKBP8 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:18,895,608...18,902,648
Ensembl chr16:18,893,576...18,902,612
|
|
G |
Fktn |
fukutin |
decreases expression |
ISO |
Fenthion results in decreased expression of FKTN mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:68,339,803...68,396,412
Ensembl chr 5:68,340,028...68,396,409
|
|
G |
Flnb |
filamin B |
decreases expression |
ISO |
Fenthion results in decreased expression of FLNB mRNA |
CTD |
PMID:34813904 |
|
NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
increases oxidation |
ISO |
FMO1 protein results in increased oxidation of Fenthion |
CTD |
PMID:14976351 |
|
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
|
|
G |
Fmo5 |
flavin containing dimethylaniline monoxygenase 5 |
increases expression |
ISO |
Fenthion results in increased expression of FMO5 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693
|
|
G |
Fntb |
farnesyltransferase, CAAX box, subunit beta |
decreases expression |
ISO |
Fenthion results in decreased expression of FNTB mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:95,536,540...95,619,587
Ensembl chr 6:95,470,683...95,619,586
|
|
G |
Focad |
focadhesin |
decreases expression |
ISO |
Fenthion results in decreased expression of FOCAD mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:102,564,560...102,886,587
Ensembl chr 5:102,564,598...102,886,582
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Fenthion results in increased expression of FOS mRNA |
CTD |
PMID:21538558 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxj2 |
forkhead box J2 |
decreases expression |
ISO |
Fenthion results in decreased expression of FOXJ2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:156,047,043...156,073,540
Ensembl chr 4:156,046,969...156,073,518
|
|
G |
Foxp1 |
forkhead box P1 |
increases expression |
ISO |
Fenthion results in increased expression of FOXP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
|
|
G |
Foxp4 |
forkhead box P4 |
increases expression |
ISO |
Fenthion results in increased expression of FOXP4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:13,058,506...13,115,406
Ensembl chr 9:13,058,476...13,114,879
|
|
G |
Fpgs |
folylpolyglutamate synthase |
decreases expression |
ISO |
Fenthion results in decreased expression of FPGS mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:15,972,800...15,993,592
Ensembl chr 3:15,972,800...15,993,563
|
|
G |
Fryl |
FRY like transcription coactivator |
decreases expression |
ISO |
Fenthion results in decreased expression of FRYL mRNA |
CTD |
PMID:34813904 |
|
NCBI chr14:34,956,623...35,189,738
Ensembl chr14:34,956,620...35,190,222
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
increases expression |
ISO |
Fenthion results in increased expression of FSCN1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
|
|
G |
Furin |
furin (paired basic amino acid cleaving enzyme) |
increases expression |
ISO |
Fenthion results in increased expression of FURIN mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:134,348,142...134,361,182
Ensembl chr 1:134,348,144...134,364,314
|
|
G |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
increases expression |
ISO |
Fenthion results in increased expression of FXYD1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:86,287,163...86,291,478
Ensembl chr 1:86,287,165...86,291,278
|
|
G |
Fyco1 |
FYVE and coiled-coil domain autophagy adaptor 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of FYCO1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:123,412,105...123,479,315
Ensembl chr 8:123,412,112...123,479,021
|
|
G |
G3bp1 |
G3BP stress granule assembly factor 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of G3BP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:39,586,864...39,620,268
Ensembl chr10:39,586,864...39,620,268
|
|
G |
Gab1 |
GRB2-associated binding protein 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GAB1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:27,131,262...27,239,236
Ensembl chr19:27,131,262...27,239,236
|
|
G |
Gabarap |
GABA type A receptor-associated protein |
increases expression |
ISO |
Fenthion results in increased expression of GABARAP mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:54,714,777...54,718,099
Ensembl chr10:54,714,198...54,717,765
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
Fenthion results in increased expression of GADD45A mRNA |
CTD |
PMID:21538558 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gak |
cyclin G associated kinase |
decreases expression |
ISO |
Fenthion results in decreased expression of GAK mRNA |
CTD |
PMID:34813904 |
|
NCBI chr14:1,089,853...1,164,098
Ensembl chr14:1,089,866...1,216,398
|
|
G |
Galm |
galactose mutarotase |
increases expression |
ISO |
Fenthion results in increased expression of GALM mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310
|
|
G |
Galnt10 |
polypeptide N-acetylgalactosaminyltransferase 10 |
decreases expression |
ISO |
Fenthion results in decreased expression of GALNT10 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:41,821,216...41,967,618
Ensembl chr10:41,820,158...41,967,013
|
|
G |
Galnt2 |
polypeptide N-acetylgalactosaminyltransferase 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of GALNT2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:52,213,226...52,324,816
Ensembl chr19:52,213,351...52,324,813
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
increases expression |
ISO |
Fenthion results in increased expression of GAPDH mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gapvd1 |
GTPase activating protein and VPS9 domains 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GAPVD1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:17,968,345...18,041,888
Ensembl chr 3:17,969,599...18,055,218
|
|
G |
Gars1 |
glycyl-tRNA synthetase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GARS1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
|
|
G |
Gatd1 |
glutamine amidotransferase class 1 domain containing 1 |
increases expression |
ISO |
Fenthion results in increased expression of GATD1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:196,504,533...196,512,561
Ensembl chr 1:196,504,833...196,512,551
|
|
G |
Gbf1 |
golgi brefeldin A resistant guanine nucleotide exchange factor 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GBF1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:245,018,535...245,147,052
Ensembl chr 1:245,018,568...245,147,042
|
|
G |
Gcdh |
glutaryl-CoA dehydrogenase |
decreases expression |
ISO |
Fenthion results in decreased expression of GCDH mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:23,263,215...23,269,689
Ensembl chr19:23,263,264...23,269,681
|
|
G |
Gcgr |
glucagon receptor |
decreases expression |
ISO |
Fenthion results in decreased expression of GCGR mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:105,808,474...105,816,641
Ensembl chr10:105,808,473...105,816,640
|
|
G |
Gchfr |
GTP cyclohydrolase I feedback regulator |
increases expression |
ISO |
Fenthion results in increased expression of GCHFR mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:106,158,046...106,162,080
Ensembl chr 3:106,159,394...106,162,080
|
|
G |
Gckr |
glucokinase regulator |
increases expression |
ISO |
Fenthion results in increased expression of GCKR mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654
|
|
G |
Gdi1 |
GDP dissociation inhibitor 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GDI1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr X:152,087,611...152,094,274
Ensembl chr X:152,087,444...152,094,272
|
|
G |
Gdpd1 |
glycerophosphodiester phosphodiesterase domain containing 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GDPD1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:71,840,497...71,883,936
Ensembl chr10:71,840,497...71,883,850
|
|
G |
Gemin7 |
gem (nuclear organelle) associated protein 7 |
increases expression |
ISO |
Fenthion results in increased expression of GEMIN7 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:79,215,054...79,228,769
Ensembl chr 1:79,214,919...79,224,994
|
|
G |
Get1 |
guided entry of tail-anchored proteins factor 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GET1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:35,438,555...35,460,156
Ensembl chr11:35,445,815...35,459,973
|
|
G |
Get3 |
guided entry of tail-anchored proteins factor 3, ATPase |
increases expression |
ISO |
Fenthion results in increased expression of GET3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:23,130,109...23,138,196
Ensembl chr19:23,130,109...23,138,193
|
|
G |
Ggcx |
gamma-glutamyl carboxylase |
decreases expression |
ISO |
Fenthion results in decreased expression of GGCX mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:104,469,737...104,485,631
Ensembl chr 4:104,469,765...104,487,063
|
|
G |
Ggnbp1 |
gametogenetin binding protein 1 |
affects expression |
ISO |
Fenthion affects the expression of GGNBP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr20:5,109,849...5,116,185
Ensembl chr20:5,099,311...5,116,183
|
|
G |
Ghdc |
GH3 domain containing |
increases expression |
ISO |
Fenthion results in increased expression of GHDC mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:85,693,612...85,697,833
Ensembl chr10:85,693,616...85,697,865
|
|
G |
Gimap1 |
GTPase, IMAP family member 1 |
increases expression |
ISO |
Fenthion results in increased expression of GIMAP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:77,687,581...77,691,468
Ensembl chr 4:77,682,171...77,691,866
|
|
G |
Gimap6 |
GTPase, IMAP family member 6 |
decreases expression |
ISO |
Fenthion results in decreased expression of GIMAP6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:77,653,703...77,659,112
Ensembl chr 4:77,652,610...77,659,116
|
|
G |
Gins1 |
GINS complex subunit 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GINS1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:139,724,513...139,745,930
Ensembl chr 3:139,724,490...139,745,936
|
|
G |
Gkap1 |
G kinase anchoring protein 1 |
increases expression |
ISO |
Fenthion results in increased expression of GKAP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr17:6,383,963...6,423,684
Ensembl chr17:6,383,963...6,423,679
|
|
G |
Gle1 |
GLE1 RNA export mediator |
decreases expression |
ISO |
Fenthion results in decreased expression of GLE1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:13,209,312...13,237,018
Ensembl chr 3:13,209,322...13,237,379
|
|
G |
Glg1 |
golgi glycoprotein 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GLG1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr19:39,124,892...39,224,178
Ensembl chr19:39,124,641...39,224,178
|
|
G |
Glrx |
glutaredoxin |
increases expression |
ISO |
Fenthion results in increased expression of GLRX mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Gltpd2 |
glycolipid transfer protein domain containing 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of GLTPD2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:55,233,563...55,236,125
Ensembl chr10:55,233,571...55,235,233
|
|
G |
Gmppa |
GDP-mannose pyrophosphorylase A |
increases expression |
ISO |
Fenthion results in increased expression of GMPPA mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:76,926,724...76,934,274
Ensembl chr 9:76,926,739...76,934,269
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
increases expression |
ISO |
Fenthion results in increased expression of GNAI2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
|
|
G |
Gnmt |
glycine N-methyltransferase |
increases expression |
ISO |
Fenthion results in increased expression of GNMT mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Golga1 |
golgin A1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GOLGA1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:22,765,690...22,812,637
Ensembl chr 3:22,767,761...22,812,585
|
|
G |
Golga2 |
golgin A2 |
decreases expression |
ISO |
Fenthion results in decreased expression of GOLGA2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:15,583,862...15,604,279
Ensembl chr 3:15,584,039...15,604,279
|
|
G |
Golga7 |
golgin A7 |
increases expression |
ISO |
Fenthion results in increased expression of GOLGA7 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:68,767,259...68,782,536
Ensembl chr16:68,767,299...68,782,511
|
|
G |
Golgb1 |
golgin B1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GOLGB1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr11:63,843,179...63,900,665
Ensembl chr11:63,843,986...63,900,770
|
|
G |
Gorasp1 |
golgi reassembly stacking protein 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GORASP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:119,655,267...119,667,022
Ensembl chr 8:119,655,268...119,666,972
|
|
G |
Gpat4 |
glycerol-3-phosphate acyltransferase 4 |
decreases expression |
ISO |
Fenthion results in decreased expression of GPAT4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:68,819,031...68,852,903
Ensembl chr16:68,819,079...68,852,901
|
|
G |
Gpatch11 |
G patch domain containing 11 |
decreases expression |
ISO |
Fenthion results in decreased expression of GPATCH11 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:16,229,933...16,243,305
Ensembl chr 6:16,233,059...16,243,238
|
|
G |
Gpbp1 |
GC-rich promoter binding protein 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GPBP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:43,023,504...43,091,146
Ensembl chr 2:43,023,504...43,090,907
|
|
G |
Gpr155 |
G protein-coupled receptor 155 |
decreases expression |
ISO |
Fenthion results in decreased expression of GPR155 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:58,216,422...58,270,350
Ensembl chr 3:58,216,423...58,270,275
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
decreases expression |
ISO |
Fenthion results in decreased expression of GPT mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
increases expression |
ISO |
Fenthion results in increased expression of GPX4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Grb7 |
growth factor receptor bound protein 7 |
decreases expression |
ISO |
Fenthion results in decreased expression of GRB7 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:83,443,387...83,453,057
Ensembl chr10:83,444,004...83,453,052
|
|
G |
Grcc10 |
gene rich cluster, C10 gene |
increases expression |
ISO |
Fenthion results in increased expression of GRCC10 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:157,551,276...157,552,924
|
|
G |
Grhpr |
glyoxylate and hydroxypyruvate reductase |
decreases expression |
ISO |
Fenthion results in decreased expression of GRHPR mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:59,234,179...59,243,614
Ensembl chr 5:59,234,192...59,243,603
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GRINA mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366
|
|
G |
Grn |
granulin precursor |
decreases expression |
ISO |
Fenthion results in decreased expression of GRN mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
|
|
G |
Gsk3a |
glycogen synthase kinase 3 alpha |
increases expression |
ISO |
Fenthion results in increased expression of GSK3A mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:80,815,843...80,825,732
Ensembl chr 1:80,815,850...80,825,802
|
|
G |
Gspt1 |
G1 to S phase transition 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GSPT1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:4,362,528...4,397,215
Ensembl chr10:4,362,510...4,397,198
|
|
G |
Gss |
glutathione synthetase |
increases expression |
ISO |
Fenthion results in increased expression of GSS mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
increases expression |
ISO |
Fenthion results in increased expression of GSTM4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
|
|
G |
Gtf2h1 |
general transcription factor IIH subunit 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GTF2H1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:97,321,417...97,349,455
Ensembl chr 1:97,321,394...97,349,455
|
|
G |
Gtf2h3 |
general transcription factor IIH subunit 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of GTF2H3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:32,009,010...32,025,484
Ensembl chr12:32,009,014...32,025,497
|
|
G |
Gtf2i |
general transcription factor II I |
decreases expression |
ISO |
Fenthion results in decreased expression of GTF2I mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:22,400,933...22,476,243
Ensembl chr12:22,401,431...22,476,243
|
|
G |
Gtpbp6 |
GTP binding protein 6 (putative) |
increases expression |
ISO |
Fenthion results in increased expression of GTPBP6 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr12:46,574,913...46,578,873
Ensembl chr12:46,574,435...46,578,873
|
|
G |
Guk1 |
guanylate kinase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of GUK1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:43,971,514...43,988,658
Ensembl chr10:43,971,509...43,980,107
|
|
G |
Gys2 |
glycogen synthase 2 |
increases expression |
ISO |
Fenthion results in increased expression of GYS2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 4:175,365,054...175,406,228
Ensembl chr 4:175,365,054...175,406,228
|
|
G |
H2ac18 |
H2A clustered histone 18 |
decreases expression |
ISO |
Fenthion results in decreased expression of H2AC18 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 2:183,808,398...183,808,992
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
Fenthion results in increased expression of H2AX protein |
CTD |
PMID:33221015 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
decreases expression |
ISO |
Fenthion results in decreased expression of H6PD mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:160,434,499...160,470,203
Ensembl chr 5:160,438,697...160,470,171
|
|
G |
Haao |
3-hydroxyanthranilate 3,4-dioxygenase |
increases expression |
ISO |
Fenthion results in increased expression of HAAO mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:10,845,235...10,864,863
Ensembl chr 6:10,845,771...10,864,877
|
|
G |
Habp2 |
hyaluronan binding protein 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of HABP2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:255,315,870...255,350,161
Ensembl chr 1:255,315,915...255,350,160
|
|
G |
Hacd1 |
3-hydroxyacyl-CoA dehydratase 1 |
increases expression |
ISO |
Fenthion results in increased expression of HACD1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr17:77,081,508...77,106,114
Ensembl chr17:77,083,740...77,106,073
|
|
G |
Hacd3 |
3-hydroxyacyl-CoA dehydratase 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of HACD3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 8:65,501,240...65,538,507
Ensembl chr 8:65,501,240...65,538,507
|
|
G |
Hapln4 |
hyaluronan and proteoglycan link protein 4 |
decreases expression |
ISO |
Fenthion results in decreased expression of HAPLN4 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr16:19,333,106...19,341,243
Ensembl chr16:19,333,106...19,341,243
|
|
G |
Hat1 |
histone acetyltransferase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of HAT1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517
|
|
G |
Hbp1 |
HMG-box transcription factor 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of HBP1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787
|
|
G |
Hbs1l |
HBS1-like translational GTPase |
decreases expression |
ISO |
Fenthion results in decreased expression of HBS1L mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 1:16,092,529...16,170,082
Ensembl chr 1:16,092,547...16,170,074
|
|
G |
Hdac2 |
histone deacetylase 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of HDAC2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
|
|
G |
Hdac3 |
histone deacetylase 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of HDAC3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
|
|
G |
Hdgfl2 |
HDGF like 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of HDGFL2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:909,581...929,195
Ensembl chr 9:909,614...929,186
|
|
G |
Hdlbp |
high density lipoprotein binding protein |
decreases expression |
ISO |
Fenthion results in decreased expression of HDLBP mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 9:93,948,099...94,018,040
Ensembl chr 9:93,949,913...94,018,048
|
|
G |
Heatr1 |
HEAT repeat containing 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of HEATR1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948
|
|
G |
Hectd1 |
HECT domain E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
Fenthion results in decreased expression of HECTD1 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 6:69,181,429...69,268,045
Ensembl chr 6:69,181,436...69,268,053
|
|
G |
Hectd3 |
HECT domain E3 ubiquitin protein ligase 3 |
decreases expression |
ISO |
Fenthion results in decreased expression of HECTD3 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 5:130,469,840...130,479,802
Ensembl chr 5:130,469,840...130,478,561
|
|
G |
Helz2 |
helicase with zinc finger 2 |
decreases expression |
ISO |
Fenthion results in decreased expression of HELZ2 mRNA |
CTD |
PMID:34813904 |
|
NCBI chr 3:168,338,813...168,353,219
Ensembl chr 3:168,338,813...168,353,159
|
|
G |
Hgs |
hepatocyte growth factor-regulated tyrosine kinase substrate |
increases expression |
ISO |
Fenthion results in increased expression of HGS mRNA |
CTD |
PMID:34813904 |
|
NCBI chr10:105,739,617...105,757,838
Ensembl chr10:105,739,296...105,757,835
|
|